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Abstract 
 
 
The heat shock transcription factor 1 is the main regulator of the mammalian heat shock response. The 
synthesis of molecular chaperones, required for proper folding, refolding and disaggregation of 
proteins is dependent on the activation of HSF1 from an inactive monomer into a DNA-bound trimer. 
The mechanism of trimerization of HSF1 was extensively studied, and recent progress led to speculate 
over a model in which the trimerization is dependent on temperature and concentration. Also, the 
existence of an equilibrium between active and inactive HSF1 under non-stress conditions was 
proposed, explaining the expression of target genes of HSF1 in the absence of cellular stress. The 
attenuation phase of the heat shock response was proposed to be regulated through a negative feed-
back mechanism in which the molecular chaperone complex Hsp70/Hsp40 represses the transcription 
activity of trimeric HSF1. The mechanism of this attenuation as well as the nature of the cochaperones 
interacting with HSF1 during that phase of the heat shock response are still unknown. 
The aim of this work was to identify new interaction partners of HSF1 during the attenuation phase, to 
characterize these interactors, and to establish their role in the heat shock cycle. The identification 
part was performed by generating a stable human cell line constitutively in a state close to the 
attenuation phase. This was achieved by overexpressing a tagged version of HSF1 in these cells, 
significantly increasing its concentration in the cytoplasm, leading to a concentration-dependent 
trimerization in the absence of stress. Moreover, this cell line was shown to be resistant to mild heat 
shock, indicating that these cells have an increased pool of molecular chaperones. 
Immunoprecipitation and shotgun proteomics identified Hsp70, Hsc70, Bag2 and Bag4 as main 
interaction partners of HSF1. The two first proteins of the list have been known for decades to interact 
with the transcription factor during the attenuation phase, but the Hsp70 nucleotide exchange factor 
Bag2 and Bag4 were interesting new potential partners, as these interactions were confirmed to be 
direct, and not only through the Hsp70 chaperone. 
Full-length Bag2 and the Bag domain of Bag4 were purified, and their activity as nucleotide exchange 
factor was investigated. Surprisingly, the Bag domain of Bag4 proved to be much more efficient than 
the full length Bag2, and both proteins were able to stimulate the ADP-release of Hsc70 better than of 
Hsp70. Both purified proteins were also able to support refolding of heat-denaturated luciferase in the 
presence of Hsc70 and the J-domain protein Hdj1. In this experiment, differences between Bag2 and 
the Bag domain of Bag4 were small. 
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Finally, the roles of these two nucleotide exchange factors were investigated in vivo. The 
overexpression of both full-length Bag2 and Bag 4 proteins in U2-OS cells led to a strong activation of 
heat shock gene transcription, even in the absence of cellular stress. The repression of HSF1 by the 
Hsp70/Hsp40 complex is most probably short-lived, as the overexpression of the two Bag proteins 
stimulates the release of trimeric HSF1, hence allowing the transcription of heat shock genes and the 
subsequent production of molecular chaperones to continue. Fragments of Bag2 and Bag4, when 
overexpressed, could not stimulate the heat shock response, hinting at the fact that both Bag domain 
and N-terminal fragment are necessary for this effect. Taken together, these results are an additional 
indication of the existence of an equilibrium between active and inactive HSF1, equilibrium which is 
displaced towards active trimeric HSF1 in the case of cellular stress. 
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Zusammenfassung 
 
 
Der Hitzeschocktranskriptionsfaktor 1 (HSF1) ist der Hauptregulator der Hitzeschockantwort bei 
Säugentieren. Die Herstellung von molekularen Chaperonen, die für eine korrekte Faltung, Rückfaltung 
und Disaggregation benötigt werden, ist abhängig von der Aktivierung von HSF1, vom inaktiven 
Monomer zum DNA-gebundenen Trimer. Der Mechanismus der Trimerisierung von HSF1 wurde 
weitreichend untersucht und neuste wissentschaftliche Fortschritte führen zu Schlussfolgerungen 
über ein Modell, in dem die Trimerisierung temperatur- und konzentrationsabhängig ist. Auch wurde 
vorgeschlagen, dass Hsf1 immer im Gleichgewicht zwischen aktivem und inaktivem Zustand vorliegt, 
wodurch die Expression von Zielgenen von HSF1 in Abwesenheit von Zellstress erklärt wird. Für die 
Attenuation der Hitzeschockantwort wurde ein negativer Rückkopplungsmechanismus vorgeschlagen, 
bei dem der molekulare Chaperonkomplex Hsp70/Hsp40 die Transkriptionsaktivität von trimerem 
HSF1 unterdrückt. Der Mechanismus dieser Attenuation sowie die Natur der Co-chaperonen, die mit 
HSF1 während dieser Phase der Hitzeschockantwort interagieren, sind noch unbekannt. 
Das Ziel dieser Arbeit war es, neue Interaktionspartner von HSF1 in der Attenuationsphase zu 
identifizieren und zu charakterisieren, und ihre Rolle im Hitzeshockzyklus zu bestimmen. Der 
Identifikationsteil wurde durch Erzeugen einer stabilen menschlichen Zelllinie, die konstitutiv in einem 
Zustand nahe der Attenuationsphase ist, durchgeführt. Dies wurde erreicht, indem eine markierte 
Version von HSF1 in diesen Zellen überexprimiert wurde. Eine deutliche Erhöhung der Konzentration 
von HSF1 im Cytoplasma in Abwensenheit von Zellstress führte zu einer konzentrationsabhängigen 
Trimerisierung von HSF1. Darüber hinaus wurde gezeigt, dass diese Zellinie gegenüber einem leichten 
Hitzeschock resistent ist, was beweist, dass sie eine erhöhte Menge an molekularen Chaperonen 
aufweist. Durch Immunopräzipitation und Shotgun Proteomics wurden Hsp70, Hsc70, Bag2 und Bag4 
als Haupt-Interaktionspartner von HSF1 identifiziert. Von den beiden ersten Proteinen der Liste ist seit 
mehreren Jahren bekannt, dass sie mit dem Transkriptionsfaktor während der Attenuationsphase 
interagieren. Die Hsp70-Nukleotid-Austauschfaktoren Bag2 und Bag4 waren als Interaktionspartner 
noch unbekannt und waren daher interessante potentielle Partner, insbesondere da gezeigt werden 
konnte, dass diese Interaktionen direkt und nicht Hsp70 vermittelt stattfindet. 
Das Bag2 Protein und die Bag-Domäne von Bag4 wurden gereinigt und ihre Aktivität als Nukleotid-
Austauschfaktoren untersucht. Überraschenderweise erwies sich die Bag-Domäne von Bag4 als viel 
effizienterer Austauschfaktor als Bag2, und beide Proteine konnten die ADP-Dissoziation von Hsc70 
besser stimulieren als von Hsp70. Beide gereinigten Proteine waren auch in der Lage, die Rückfaltung 
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von hitzedenaturierter Luziferase in Gegenwart von Hsc70 und dem J-Domänenprotein Hdj1 zu 
unterstützen. In diesem Experiment wurden keinen signifikanten Unterschiede zwischen Bag2 und der 
Bag-Domäne von Bag4 beobachtet. 
Schließlich wurden die Rollen dieser beiden Nukleotid-Austauschfaktoren in vivo untersucht. Die 
Überexpression beider volllängen Bag-Proteine in U2OS-Zellen führte zu einer starken Aktivierung von 
HSF1, auch ohne Zellstress. Die Repression von HSF1 durch den Hsp70/Hsp40-Komplex ist 
höchstwahrscheinlich dadurch reduziert, dass die Überexpression der beiden Bag-Proteine die 
Dissoziation von trimerischem HSF1 stimuliert und somit die Transkription von Hitzeschock-Genen und 
die anschließende Produktion von molekularen Chaperonen fördert. Fragmente von Bag2 und Bag4 
konnten die Hitzeschockantwort nicht stimulieren, was darauf hinweist, dass sowohl Bag-Domäne als 
auch N-terminales Fragment für diesen Effekt notwendig sind. Zusammengefasst sind diese Ergebnisse 
ein zusätzlicher Hinweis für die Existenz eines Gleichgewichts zwischen aktivem und inaktivem HSF1. 
Dieser Gleichgewicht wird bei zellulärer Belastung zum aktiven trimerischen HSF1 verschoben. 
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Chapter 1. Introduction 
 
1.1 Chaperone proteins  
 
Proteins must adopt a specific tridimensional structure to fulfil their respective roles. This 
tridimensional structure is obtained through a specific folding. Disruption in the folding process can 
lead to non-active misfolded proteins which, in turn, can form aggregates. In the middle of the XXth 
century, “the thermodynamic hypothesis” speculated that the structure of a protein was solely 
determined by its amino acid sequence (Anfinsen 1973). In this theory, the native state of a protein 
would be its thermodynamically most stable state, with the lowest Gibbs free energy. However, 
Anfinsen was able to fold and refold proteins at low temperature and low concentration. These 
conditions are not respected in living cells, where in addition many more proteins are expressed 
simultaneously.   
Newly synthetized proteins as well as already misfolded proteins require the help of a whole class of 
proteins, called molecular chaperones, in order to go from a linear chain of amino-acids into a well-
folded functional protein. Most of the time, this would require energy in the form of ATP. Cellular 
stresses, such as temperature increase, or change of pH can lead to an increase of protein denaturation 
which can result in non-functional proteins, or even in cytotoxic aggregates (Morimoto 1998; Richter 
et al. 2010), and therefore to cellular death. Molecular chaperones are able to prevent the excessive 
accumulation of denaturated proteins, and hence the formation of toxic protein aggregates (Frydman 
2001). 
Chaperones have been reported to prevent aggregation, to fold newly synthetized and refold 
misfolded proteins, and also to dissolve protein aggregates. Prevention of aggregation is believed to 
happen through binding of the chaperone to exposed hydrophobic regions of the misfolded protein. 
Hence, these regions will not stabilize themselves by interacting with other exposed hydrophobic 
regions of other proteins (Haslbeck et al. 2005). Folding, unfolding and refolding of proteins implies 
however the need of ATP hydrolysis to accompany a succession of binding and release of the substrate, 
each cycle bringing it closer to its native state. Chaperone disaggregase activity requires the 
cooperation of several chaperones (Goloubinoff et al. 1999; Sousa 2014). 
Many chaperones are heat shock proteins (Hsp). This name describes the fact that the expression of 
these chaperones is highly up-regulated upon elevated temperature, or other stresses.  
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1.2 The Heat Shock response 
 
As mentioned earlier, the nature of cellular stresses can vary: oxidative stress, change of temperature, 
pH or osmolarity, reactive oxygen species, presence of heavy metals, or other types of physical and 
chemical changes of the environment. These stresses can lead to chemical changes in contact between 
amino-acid residues, and therefore to changes in the tridimensional structure of the protein they form. 
These changes can lead to the loss of function of the protein, and to formation of protein aggregates 
that can be harmful for the cell. To counter this, cells evolve a highly sophisticated mechanism to 
increase the amount of chaperone proteins in the cell. This mechanism is called the Heat Shock 
response (HSR). 
In the 1960’s, geneticists accidentally observed chromosomal puffs in drosophila larvae when these 
were exposed to higher temperature, resulting in the idea of the transient up-regulation of the 
transcription of certain genes upon temperature stress (Ritossa 1962). Today, it is known that the Heat 
Shock response is characterized by significant decrease in total gene transcription, while a specific set 
of genes known as heat shock genes and coding for heat shock proteins are heavily over-expressed 
(Heikkila et al. 1982; Ashburner & Bonnert 1979; Hightower 1980). The function of these heat shock 
proteins is to attenuate the effect of the proteotoxic stress, by facilitating the folding of unfolded and 
misfolded proteins (Diamant et al. 2001; Pinto et al. 1991; Martin et al. 1992). In summary, the Heat 
Shock response is the phenomenon in which global protein expression decreases, but the synthesis of 
heat shock proteins increases (Anckar & Sistonen 2011). 
In prokaryotes, a transcription factor called σ32 directs the core bacterial RNA polymerase to the 
promoters of heat shock protein. Under normal condition, σ32 is an unstable protein and is targeted 
for degradation by the DnaK chaperone, but its stability and transcriptional efficiency increases during 
heat shock, hence its concentration (Straus et al. 1990). 
It was established in the 1990s that the regulator of the Heat Shock response in eukaryotic cells is a 
transcription factor called Heat Shock Factor 1 or HSF1(Wu 1995).  In metazoan, HSF1 is inactive as a 
monomer, but acquires its DNA-binding capacity by forming a trimer. HSF1 binds to extended repeats 
of the sequence nGAAn, called Heat Shock Elements (hereafter called HSE), which are abundantly 
present in the promoters of heat shock genes (Littlefield & Nelson 1999; Xiao & Lis 1987; Amin et al. 
1988). 
In yeast, a single heat shock factor exists. It is constitutively trimeric, and is bound to HSE even in the 
absence of stress. Post-translational modifications such as phosphorylation, and release of interaction 
partners trigger its transcriptional activity (Sorger & Pelham 1987; Westwoodt & Wu 1993; Santoro et 
al. 1998). 
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In mammals, five HSF were identified so far (HSF1, HSF2, HSF3, HSF X and HSF Y), but only HSF1 has an 
irreplaceable role in the Heat Shock response (Mcmillan et al. 1998) . HSF2 and HSF3 were shown to 
interact with HSF1 during the HSR , in order to modulate the transcription of Heat Shock proteins 
(Sandqvist et al. 2009; Jaeger et al. 2016), but their major role seems to be linked with development 
(Åkerfelt et al. 2007; Östling et al. 2007). HSF2 was also suggested to bind promoters of heat shock 
proteins during mitosis, so that HSF1-mediated transcription can start directly after the end of cell-
division (Xing et al. 2005). HSF Y was reported to play a role in spermatogenesis (Shinka et al. 2004) 
and the function of HSF X is still unknown.  
 
1.3 Heat Shock transcription Factor 1 
 
1.3.1 The different domains of HSF1 
 
Most probably due to HSF1’s flexibility, only partial structural information is available on HSF1. 
Different domains were identified, but their lack of defined structure proved to be challenging in 
obtaining significant insight on a global structure of the protein.    
 
 
 
 
 
 
 
 
 
 
 
In fact, the only domain tridimensional structure of HSF1 is the one of its DNA-binding domain (DBD). 
HSF1’s DBD is, as many other DBD of transcription factors, of a looped helix-turn-helix type. However, 
unlike other DBD of this type, the loop does not make direct contact with DNA, but was proposed to 
stabilize the trimer, by interacting with a DBD of another HSF1 (Vuister et al. 1994; Littlefield & Nelson 
1999). It was then suggested that the loop is required for full activity, and its deletion would lead to a 
weakened DNA-binding (Cicero et al. 2001). More recently, a structure of the trimeric human DBD 
bound to DNA, along with parts of the HR-A/B was proposed (Neudegger et al. 2016). In this structure, 
as well as in some previously published studies, each DBD of a HSF1 trimer recognizes a single nGAAn 
15 110 130 221 203 384 383 529 410 409 
DBD HR-A/B HR-C RD TAD 
Figure 1: Domain structure of human HSF1. The DNA-binding domain (DBD, orange) is located at the N-
terminus of the protein. It is the most conserved domain of HSF1. The amphiphilic heptad repeats HR-A and 
HR-B (magenta) are involved in the formation of trimers with other molecules of HSF1. The regulatory domain 
(RD, green) is subject to many post-translational modification and modulates the transcriptional activity of 
HSF1 by acting on its transactivation domain (TAD, blue), located at the C-terminus. Between RD and TAD, the 
heptad repeat HR-C interacts with HR-A/B and prevents trimerization. 
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repeat in the major groove of the DNA helix and binds to it (Littlefield & Nelson 1999; Amin et al. 1988; 
Xiao & Lis 1987). 
The oligomerization domain of HSF1 is located at the C-terminus of the DBD, and includes both HR-A 
and HR-B. In the trimeric form of HSF1, circular dichroism studies and X-ray crystallography proved this 
domain to be made of a triple α-helix coiled-coil, formed by the hydrophobic heptad repeat HR-A and 
HR-B (Peteranderl & Nelson 1992; Neudegger et al. 2016). In the absence of any stress, it has been 
shown that spontaneous oligomerization is prevented by the amphiphilic heptad repeat HR-C, 
interacting with HR-A/B through an intramolecular leucine zipper (Rabindran et al. 1993; Hentze et al. 
2016). This was confirmed by mutational analysis, where mutants lacking some hydrophobic residues 
in the HR-C heptad repeat would be constitutively trimeric (Rabindran et al. 1993; Zuo et al. 1994). 
Consequently, the transition from monomer to trimer goes from an intramolecular coiled-coil to an 
intermolecular coiled-coil. 
 
The region framed by HR-A/B and HR-C is known as the regulatory domain (RD). Upon stress, the RD 
undergoes a great number of posttranslational modification : 19 phosphorylation sites were identified, 
as well as some acetylation sites, and one phosphorylation dependent sumoylation site (Kline & 
Morimoto 1997; Hietakangas et al. 2003; Guettouche et al. 2005; Hietakangas et al. 2006). 
Phosphorylation were shown to either repress the transactivation activity of HSF1 (serine 303 and 
serine 307), or, in the case of Phosphoserines 320 and 326, to play a critical role in the induction of 
HSF1 (Holmberg et al. 2001; Guettouche et al. 2005). The sumoylation of lysine 298 was shown to be 
dependent on the phosphorylation of serine 303, and was able to repress transcriptional activity of 
HSF1. Desumoylation was interestingly shown to be temperature dependent: mild heat shock leads to 
a slow removal of the SUMO protein from K298, whereas acute temperature stress was accompanied 
by rapid desumoylation, hence contributing to a strong heat shock response (Anckar et al. 2006). The 
mechanism by which SUMO delayed the HSR is still unclear. Acting as a regulator of HSF1 stability, 
conformation or localization has to be considered (Geiss-friedlander & Melchior 2007). 
 
The very C-terminal part of HSF1 is called the transactivation domain (TAD). Its role is to regulate the 
magnitude of HSF1 activation, and altogether to facilitate the transcription to target genes. Despite 
being globally unfolded, it contains a small α-helical hydrophobic motif which interacts in vitro with 
the basal transcription component TAF-9 (Choi 2000). Mutations of hydrophobic residues contained in 
this motif reduces HSF1 trans-activation capacity (Newton et al. 1996). The TAD is rich in hydrophobic 
and acidic residues, but also rich in proline, which attests for a global absence of α-helices. An 
interaction between some hydrophobic residues and BRG1, the ATPase subunit of the chromatin 
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remodeler SWI/SNF, was also reported (Sullivan et al. 2001). The SWI/SNF complex is required for heat-
inducible chromatin remodeling of heat-shock genes (Corey et al. 2003). 
  
1.3.2 Localization of HSF1 
 
HSF1 was detected both in the cytoplasm and the nucleus, but its concentration in the nucleus 
increases after cellular stress (Sarge et al. 1993; Brown & Rush 1999; Mercier et al. 1999; Stacchiotti et 
al. 1999). In addition, it was shown that the import of HSF1 from the cytoplasm to the nucleus was 
under the control of the relatively potent importin-α/β, and that this import was more efficient than 
the export from the nucleus pathway, which is not under the control of the classical exportin-1 system 
(Vujanac et al. 2005). More recently, it was shown that HSF1 co-translocated from the cytosol to the 
nucleus with Bag3, a co-chaperone of the Hsp70 family, and that the shuttling of HSF1 is hindered with 
lower levels of Bag3 (Jin et al. 2015). Moreover, a simultaneous translocation to the nucleus of HSF1 
with the E3- ubiquitin ligase CHIP has also been reported (Dai et al. 2003), but in that case, CHIP was 
promoting HSF1 trimerization, and it was unclear whether the transport of HSF1 was really CHIP-
dependent. In this study, CHIP (-/-) mice were temperature-sensitive, and unable to mount a heat 
shock response (Dai et al. 2003). 
 
1.3.3 HSF1-mediated transactivation of heat shock genes 
 
 
It is established that HSF1 is the main player in the cellular stress response. The rapid expression of 
heat shock genes following temperature stress has served as model for transcriptional response 
studies. Indeed, the expression of HSP70 upon protein-damaging stress is one of the best-understood 
models for the activation of transcription. In D. melanogaster, the HSP70 promoter is constitutively 
primed for activation by a complex formed by the GAGA factor, the transcription factor IID, and a 
paused RNA polymerase II (Rougvie & Lis 1988; Rasmussen & Lis 1993). Moreover, it was suggested 
that the presence of this paused complex is critical for HSF1 binding in vivo (Shopland et al. 1995). 
Upon cellular stress, HSF rapidly accumulates at the promoter, recruiting the mediator complex and 
the transcription elongation factor p-TEFb (Lis et al. 2000). To facilitate transcription elongation, 
topoisomerase I relieves DNA coiling (Gilmour et al. 1988), and the FACT complex removes 
nucleosomes (Andrulis et al. 2000). Similar mechanisms can be found in mammals, such as the HSF1-
dependent release of RNA Pol II, and the removal of nucleosomes downstream of the polymerase 
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(Brown et al. 1996). More recently, HSF1 has been shown to interact with replication factor A (RPA) 
and with FACT to maintain the HSP70 promotor highly accessible for HSF1 (Fujimoto et al. 2012). 
 
1.3.4 Regulation of the HSF1 activation-attenuation cycle 
 
1.3.3.1 Activation of HSF1 
 
 
Since the discovery of its role, the mechanism of activation of HSF1 has been extensively studied in 
models ranging from cell culture assays to the level of full-organism in nematodes, mice or rats. In 
general, monomeric HSF1 trimerizes upon stress and leads to the synthesis of heat shock proteins, 
and, after some time, the stress response decreases in intensity. Some heat shock proteins are 
molecular chaperones, and hence protect the cell from proteotoxic damages and help in maintaining 
protein homeostasis. In time, when the concentration of molecular chaperones had increased to levels 
more adapted to the needs of the cells, an attenuation of HSF1 transcriptional activity happens most 
likely through a negative feedback loop. The chaperones were proposed to interact with the 
hydrophobic and unstructured transactivation domain of HSF1 (Abravaya et al. 1991a; Shi et al. 1998a). 
HSF1 activation is not completely understood, and several theories describing mechanisms of 
activation were proposed so far. 
 
The first model thought came out of observations that monomeric HSF1 can trimerize and acquire its 
DNA-binding capacity in vitro when exposed to higher temperatures (Mosser et al. 1990; Goodson & 
Sarge 1995; Farkas et al. 1998). This observation lead to the development of the “intrinsic response” 
activation model, in which HSF1 is able to “sense” temperature changes, and undergoes 
conformational changes leading to trimerization. Advocates of this model identified the α-helical 
amphiphilic heptad repeats HR-A/B and HR-C, which were believed to interact with each other in the 
inactive form (Rabindran et al. 1993), hence preventing HSF1 to trimerize. Mutations in these heptads 
repeats disrupted these interactions, and HSF1 was found to be constitutively trimeric. More recently, 
Hydrogen Exchange Mass Spectrometry measurements could confirm the interaction between HR-C 
and HR-A/B in monomeric HSF1. This interaction was however not visible when measuring trimeric 
HSF1, hence confirming the validity of this model (Hentze et al. 2016). Moreover, it was shown that 
the disruption of the Leucine zipper interaction between HR-A/B and HR-C was not only temperature- 
dependent, but also concentration-dependent. In fact, the temperature of activation of HSF1, would 
be reduced in higher concentration of purified HSF1 (Hentze et al. 2016). 
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The second model, called “chaperone titration” is based on the fact that HSF1 was shown to interact 
with heat shock proteins (Shi et al. 1998a; Zou et al. 1998; Neef et al. 2014). This model was established 
when HSF1’s activity was shown to be repressed by a multi-chaperone complex containing Hsp90, and 
depletion of Hsp90 lead to immediate HSF1 activation (Zou et al. 1998; Ali et al. 1998; Guo et al. 2001). 
In addition, it was shown that elevated levels of Hsp70 and Hsp90 were able to prevent trimerization 
of HSF1 (Shi et al. 1998b). Also, Hsp90 inhibitors could trigger HSF1 stress response pathway in mice 
(Lee et al. 2013). According to this model, the accumulation of misfolded proteins would titrate heat 
shock proteins away from HSF1, hence allowing it to trimerize. However, other evidences suggested 
that rather than maintaining it inactive or inhibiting its DNA binding, Hsp90 broadens HSF1 activation 
temperature window (Hentze et al. 2016). Other data mentioned the interaction between Hsp90 and 
HSF1, but only after DSP-crosslinking, suggesting a very transient interaction. In addition, the same 
study reveals an interaction between inactive HSF1 and the cytosolic chaperonin TRiC/CCT. This 
interaction could be disrupted by the small molecule HSF1A, a chemical activator of the heat shock 
response (Neef et al. 2014). More recently, it was suggested that Hsp70 and Hsp40, a J-domain protein, 
prevents transactivation of HSF1 in yeast, and that the growth defect caused by HSF1 overexpression 
could be partially suppressed by overexpressing Hsp70 and Hsp40 (Zheng et al. 2016). This chaperone 
titration theory was modelized in mammalian organism by Sivéry and colleagues (Sivéry et al. 2016). 
 
Another model of HSF1 activation is based on the existence of a ribonucleoprotein complex consisting 
of the translation elongation factor eEF1A and a constitutively expressed non-coding RNA called heat 
shock RNA-1 (HSR-1) (Shamovsky et al. 2006). In this model, the non-coding RNA directly acts as a 
thermosensor, and undergoes changes in secondary structures upon stress (Kugel & Goodrich 2006). 
It can then interact with eEF1A, which became available due to the global shut-down of protein 
synthesis, and in turn with HSF1, promoting its trimerization (Shamovsky & Nudler 2008). 
 
The last activation model concerns whole organisms. It is based on the discovery of thermosensory 
neurons (called AFDs) in C. elegans (Clark et al. 2007), and on the fact that activation of HSF1 may 
depend on these neurons (Prahlad et al. 2008). Living nematodes with disrupted AFDs were shown not 
to display a cellular heat shock response in the tissue where the heat shock was applied, but also in 
remote parts of the organism (Prahlad & Morimoto 2009). More recently, it was shown that excitation 
of AFDs was not enough to trigger the HSR in remote cells, but that this activation of HSF1 needed the 
release of neuronal serotonin in the specific tissue. Serotonin was shown to be released following AFD 
excitation, even in the absence of temperature increase (Tatum et al. 2015). 
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These four models are not necessarily mutually exclusive, and could happen simultaneously in vivo, 
hence leading to a very fast setting up of the heat shock response.  
 
1.3.3.2 Attenuation of the heat shock response 
 
It is commonly accepted that the heat shock response undergoes an attenuation phase, when the 
synthesis of more heat shock proteins is not needed anymore. Two distinct pathways were proposed 
so far: the negative feed-back loop and the acetylation of HSF1. 
The negative feed-back loop relies on the idea that an excess of molecular chaperones that was 
synthetized during the heat shock response interacts with trimers of HSF1, hence repressing its 
transcriptional activity (Mosser et al. 1988). Evidences of a protein-protein interaction between HSF1 
and the Hsp70/Hsp40 complex were shown at the late stages of the heat shock response (Mosser et 
al. 1988; Abravaya et al. 1991b; Baler et al. 1992; Shi et al. 1998b), and a possible recruitment of the 
transcriptional repressor CoREST through Hsp70/Hsp40 was suggested, as down-regulation of CoREST 
rendered Hsp70 incapable of repressing HSF1-dependent transcription  (Gómez et al. 2008). However, 
the interaction of HSF1 with Hsp70 does not suppress the DNA-binding activity of the trimer of HSF1, 
suggesting another mechanism at play (Rabindran et al. 1994; Shi et al. 1998b). Hsp90 was also 
reported to interact with the Regulatory Domain of trimeric HSF1 in heat-shocked cells, but only as a 
complex with FKBP52 and p23 (Ali et al. 1998; Bharadwaj et al. 1999; Guo et al. 2001). Disruption of 
this complex lead to a delayed attenuation phase, suggesting that it could also play a role in HSF1’s 
attenuation.  
The acetylation pathway has been shown to be responsible for the disruption of the interaction 
between HSE-containing DNA and trimeric HSF1. In heat-shocked cells, HSF1’s acetylation gradually 
increases, and inhibition of sirtuins, a family of deacetylase, lead to increase the levels of acetylation, 
and reduced amount of Hsp70 produced after heat shock in vivo. On the contrary, overexpression of 
the deacetylase SIRT1 significant reduced HSF1 acetylation, and  heat shock genes promoter occupancy 
(Westerheide et al. 2009). Among the nine lysines that were stated to be acetylation site of HSF1, Lys80 
was reported to be the one whose acetylation by the acetyl-transferase p300-CBP (CREB-binding 
protein) would lead to a decrease in DNA-bound HSF1. In addition, the acetylation of Lys80 was 
reported to have a role to play in HSF1 degradation by the proteasome system, hence contributing 
even more to the attenuation of the heat shock response (Westerheide et al. 2009; Raychaudhuri et 
al. 2014). 
The most recent model of HSF1 activation/attenuation cycle is presented in figure 2. 
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Figure 2: The Heat-Shock response. In the absence of stress (1), HSF1 is monomeric and inactive. Upon 
stress, the “chaperone cage” is titrated away, and disruption of the intra-molecular leucine-zipper 
occurs (2). HSF1 then undergoes several post-translational modifications such as phosphorylation and 
sumoylation, trimerizes, and acquires its DNA-binding capacity. The trimer binds to HSE in the 
promoter of heat shock genes, and drives the transcription of heat shock genes (3). Attenuation of the 
heat-shock response starts as a negative feed-back regulation, when Hsp70 and JDP bind to the TAD, 
and represses the transcription of heat shock genes (4). Trimeric HSF1 is undocked from the DNA after 
acetylation of Lys80 located in the DBD, and according to some studies, HSF1 is then targeted for 
degradation (5). 
 
1.3.5 Other roles of HSF1 
 
 
HSF1 is involved in cellular pathway other than the heat shock response. Several studies report an 
implication of HSF1 in the absence of stress in other cellular mechanisms such as development 
regulation, disease or insulin signaling.  
Although not required for survival in adulthood in mammals, HSF1 deficient mice exhibit prenatal 
lethality, growth retardation, and abnormally regulated cytokine production (Xiao et al. 1999; 
Christians et al. 2000; Inouye et al. 2004). Evidence was provided that HSF1 fulfils its developmental 
functions through an activation mechanism different from- the one that applies to stressed cells 
(Åkerfelt et al. 2010; Fujimoto et al. 2004; Masson et al. 2011). The regulation of HSF1’s activity was 
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also shown to be critical in the case of its developmental role, as Hsf1 -/- mice have a spermatogenesis 
defect (Salmand et al. 2008), and constitutively active HSF1 renders mice infertile (Nakai et al. 2000). 
HSF1 was also shown to be involved in processes critical for the survival of malignant cells. Indeed, Dai 
and colleagues showed that Hsf1 -/- mice were highly resistant to treatment leading normally to 
tumorigenesis. In addition, in cell culture, HSF1 modulates pathways needed for cancer cell survival, 
such as Protein Kinase A activation, or glucose metabolism (Dai et al. 2007). This link between HSF1 
and cancer can be easily explained by the fact that cancer cells are dependent on higher amounts of 
molecular chaperones for survival, and therefore on a stronger activation of HSF1 (Whitesell & 
Lindquist 2009). Another model is built on evidences that HSF1 and the transcription factor FOXO are 
both silenced by insulin signaling (Cohen et al. 2006; Hsu et al. 2003), hence suggesting a role of HSF1 
in expanding lifespan in C. elegans (Morley & Morimoto 2004). 
 
1.4 Overview of Hsp70’s role and mechanism of action 
 
 
According to the broadly accepted model of activation and attenuation of the heat shock response, 
molecular chaperones interact with HSF1 at many points during the cycle. Hsp90, the chaperonin 
complex TRiC/CCT or Hsp70 were all reported to maintain HSF1 inactive (Zou et al. 1998; Guo et al. 
2001; Neef et al. 2014; Shi et al. 1998b). During the attenuation phase, it is mainly established that 
Hsf1 is a substrate of the Hsp70/Hsp40 machinery. Hsp70 thereby has a central role in the heat shock 
response, but also in HSF1’s regulation. 
 
1.4.1 Hsp70s’ functions in the cell 
 
The 70 kDa heat shock protein is one of the most studied molecular chaperones. It performs many 
functions under stress conditions, but also in optimal growth conditions (Richter et al. 2010). 
Interacting with the polypeptide nascent chain directly at its exit from the ribosome tunnels (Deuerling 
et al. 1999; Teter et al. 1999), chaperones from the Hsp70 family bind to solvent accessible 
hydrophobic zones rich in positively charged residues of their substrate proteins. The binding in an 
ATP-dependent manner of Hsp70 at these hydrophobic clusters therefore prevents protein-protein 
aggregation, and assists in protein folding. Later in the process, if it is needed, Hsp70 hands these 
partially folded substrates to the Hsp60 (TRiC/CCT in mammals) or Hsp90 machinery (Young et al. 2004; 
Li et al. 2012). 
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As mentioned earlier, Hsp70s are overexpressed during cellular stress, when proteins are likely to be 
misfolded and to aggregate. In collaboration with molecular chaperones of the Hsp100s family, Hsp70s 
are able to dissolve protein aggregate, and subsequently refold their substrate to their native form 
(Chiti & Dobson 2006; Mayer & Bukau 2005). In that case, Hsp70s extricate a fragment of the 
aggregated protein, hands it to Hsp100 for disaggregation, and then promotes its refolding (Glover & 
Lindquist 1998; Goloubinoff et al. 1999; Liberek et al. 2008; Weibezahn et al. 2004), hence preventing 
the accumulation of proteotoxic aggregates, lethal to the cell. 
 Hsp70s are also involved in protein translocation into organelles. Indeed, it was proposed that 
cytoplasmic Hsp70 prevents aggregation of protein before translocation, maybe by keeping the transit 
peptide soluble. Hsp70 may keep the protein in a partially-folded state, which is appropriate for 
membrane transport. Meanwhile the mitochondrial Hsp70 binds the substrate when it emerges from 
the translocation pore, and assists the process until complete translocation (Neupert & Brunner 2002; 
Wiedemann et al. 2004). 
In addition to its protein folding and refolding roles, it was shown that Hsp70s can play a critical role 
in targeting protein for degradation. The interaction of heat shock cognate 70, the constitutively 
expressed Hsp70 in the cytosol, with the ubiquitin E3 ligase CHIP is well established (Connell et al. 
2001; Meacham et al. 2001; Höhfeld et al. 2001), and it was suggested that CHIP polyubiquitinylates 
substrates of Hsc70 which underwent too many association dissociation cycles. Substrates that are 
only associate for a short time with Hsc70 (i.e. which are folded/refolded quickly to their native state) 
are therefore less likely to be targeted for degradation (Stankiewicz et al. 2010). 
Through their protective roles, Hsp70s are known to allow the survival of cancer cells (Nylandsted et 
al. 2000; Shin et al. 2003), and inhibition of Hsp70s is a long-thought strategy to treat cancer patients 
(Mckeon et al. 2016). On the contrary, it has been shown that overexpression of Hsp70 mildens 
symptoms of neurodegenerative diseases such as Alzheimer’s disease, or Parkinson’s disease (Klucken 
et al. 2004; Auluck et al. 2002; Bonini 2002). In a similar manner, induction of Hsp70 through chemical-
activation of HSF1 was shown to reduce α-synuclein aggregation in cells (Kilpatrick et al. 2013). The 
connection between HSF1 and Hsp70 is therefore in the center of pathways involved in oncogenesis 
and neurodegeneration, hence accentuating the necessity of understanding the molecular 
mechanisms that regulate Hsp70. 
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1.4.2 Mechanism of action of Hsp70 
 
Hsp70 is evolutionary highly conserved. From the bacterial DnaK to the human Hsp70, all homologs of 
Hsp70 consist of a 45kDa N-terminal nucleotide binding domain (NBD), and a 25 kDa C-terminal 
substrate binding domain (SBD), which is in turn composed of a β-sandwich sub-domain that contains 
a hydrophobic cleft for client binding, and a helical lid sub-domain that controls access to the cleft 
(Pellecchia et al. 2000). Both domains are connected by a hydrophobic linker. Hsp70 functions in 
cooperation with a J-domain protein (JDP), and with a nucleotide exchange factor. The ATPase cycle of 
Hsp70 (see figure 3) is a succession of an ATP-bound state characterized by low affinity for its substrate, 
and an ADP-bound state with high substrate-affinity (Schmid et al. 1994; Mayer, Schröder, et al. 2000). 
 
 
Figure 3: Hsc70 cycle. Hsp70 cycles between the ATP-bound state and the ADP-bound state. The first 
one has low affinity and high exchange for its substrate, whereas the latter one is characterized by low 
exchange rates and high affinity for its substrate (S, in blue). ATP or ADP binds to the nucleotide binding 
domain (NBD, in green), and the substrate binds to the substrate binding domain (SBD, in red). The 
cycle is controlled by internal allostery and these conformation changes are catalyzed by co-
chaperones. The J-domain protein (JDP, in brown) provides the substrate to the SBD and stimulates 
ATP hydrolysis, resulting in strong binding of the substrate. Nucleotide exchange factors (NEF) facilitate 
ADP release, hence allowing the binding of a new molecule of ATP, and subsequently the release of 
the substrate. 
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At the beginning of the cycle, the JDP provides the substrate to the SBD of Hsp70, and stimulates ATP 
hydrolysis by the NBD (Gamer et al. 1996; Karzai & Mcmacken 1996; Kampinga & Craig 2010). ATP 
hydrolysis increases the affinity of the SBD for its substrate, hence leading to its entrapment. The 
release of the substrate is highly stimulated through the binding of a new molecule of ATP, hence 
through the release of ADP. This rate-limiting step is highly stimulated by nucleotide exchange factors 
(NEF). 
Two alternatives models have been proposed to explain the mechanism of action of Hsp70. The first 
one, called “kinetic partitioning”, is based on the fact that protein aggregation is a concentration 
dependent process. The model proposes that Hsp70 binds misfolded proteins, hence reducing the 
concentration of misfolded protein available for aggregation and allowing more time to fold correctly. 
This model assumes that Hsp70 undergoes no active change in conformation, which is unlikely. In the 
second model, Hsp70 locally unfolds some misfolded proteins, allowing them to refold, this time 
correctly (Ben-zvi & Goloubinoff 2001; Pierpaoli et al. 1997; Mayer, Rüdiger, et al. 2000; Slepenkov & 
Witt 2002). 
 
1.4.3 J-domains proteins and nucleotide exchange factors 
 
In order for the Hsp70 cycle to function at an efficient pace, co-chaperones such as J –domain proteins 
or NEF are needed. J-domain proteins (JDP), are proposed to bind substrates, before delivering them 
to Hsp70, while stimulating its ATPase activity. Many different JDPs exist, and they differ in their 
function, as well as in their domain composition (Kelley 1998). For instance, six JDPs exist in E. coli, and 
so far 44 (not counting splice variants) have been identified in human cells. All three classes of JDP 
have the J-domain in common, through which a JDP interacts with Hsp70 (Wall et al. 1994; Genevaux 
et al. 2002). 
In the presence of JDP, the release of ADP is a rate-limiting step. It is however stimulated by the action 
of nucleotide exchange factors (Liberek et al. 1991; Gässler et al. 2001; Brehmer et al. 2001). In 
bacteria, only one NEF is present, called GrpE, and its homologs are conserved in mitochondria and 
chloroplasts of eukaryotic cells. In the cytoplasm and the endoplasmic reticulum of eukaryotes 
however, three divergent families of NEF have been identified: the Hsp110/Grp170 family (four 
different proteins), the HspBP1/Sil1 family (two members), and the Bag-domain protein family (Bag1 
to Bag6) (Hohfeld & Jentsch 1998; Kabani, Beckerich, et al. 2002; Kabani, McLellan, et al. 2002; Steel 
et al. 2004; Dragovic et al. 2006; Raviol et al. 2006). This diversity of NEF was suggested to contribute 
to the appropriate allocation of Hsp70 folding capacity within the proteostasis network (Bracher & 
Verghese 2015). Even though the NEFs from the three different families are structurally different, they 
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all seem to target the IIb sub-domain of the nucleotide binding domain of Hsp70 hence stabilizing the 
NBD into its open conformation (Sondermann et al. 2001; Polier et al. 2008; Shomura et al. 2005). Both 
Hsp110 and Bag proteins possess a 3 helix bundle (3HBD for Hsp110/Bag domain for Bag proteins). In 
Bag proteins, the three-helix bundle binds IIb and Ib and thereby pries open the nucleotide binding 
cleft. In Hsp110s, the 3HBD binds to the outside of IIb, and the NBD of HSP110 is interacting with the 
NBD of Hsp70 to open the nucleotide binding cleft. In the case of the human HspBP1, four Armadillo 
repeats capped at each end with a α-helix pair wrap the IIb sub-domain. This leads to displacement of 
the Ib sub-domain of Hsp70s’ NBD, and local unfolding of the complex (Shomura et al. 2005). The six 
Bag proteins all possess this C-terminal α-helix bundle called the Bag domain. However, the Bag 
domains of Bag3, Bag4 and Bag5 form shorter three-helix bundles than Bag1, the first Bag protein to 
be characterized (Briknarová et al. 2002; Brockmann et al. 2004; Arakawa et al. 2010). Bag2 bag 
domain, on the other hand, possesses three α-helices, and two of them were reported to be able to 
form homodimers with two helices of the Bag domain of another Bag2 molecule. This Bag domain was 
dubbed Brand New Bag domain, or BNB (Xu et al. 2008). 
 
Figure 4: Structure of nucleotide exchange factors bound to Hsp70 (adapted from Polier et al (2008) 
and Shomura et al (2005)). (A) Frontal view of the crystal structure of Sse1p.ATP-Hsp70 NBD complex. 
Sse1 is the yeast Hsp110. The triple helix bundle domain (3HBD) interacts with the IIb sub-domain of 
Hsp70s’ NBD, while the NBD of Hsp110 lead to an opening of the cleft between Ib and IIb of 21°. (B) 
Top view of the crystal structure of human HspBP1 core domain (BP1c) in complex with Hsp70s’ NBD. 
The concave face of the four Armadillo repeats wraps around the IIb sub-domain. (C) Top view of the 
crystal structure of human Bag1 Bag domain (BAG) in complex with Hsc70’s NBD. As for Sse1, the sub-
domain IIb rotates away from Ib (14°C). 
 
The diversity of NEFs in eukaryotic cells might allow fine-tuning of the Hsp70 cycling rate which might 
be needed for different substrates. Rauch and colleagues showed that certain Hsp70/JDP/NEF are 
more or less efficient in refolding thermally denaturated firefly luciferase (Rauch & Gestwicki 2014). 
It is however not known how specific combinations made of Hsp70, JDP and NEF are able to select 
suitable clients. 
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Chapter 2. Aim of the thesis 
 
 
Since the beginning of the 1980s, HSF1 has been extensively studied. Its crucial role in the cellular 
stress response mechanism, alongside its complex mechanism of activation from inactive monomer to 
transcriptionally active homotrimer were solid reasons for researchers to investigate the role of this 
protein. In the late 90s, HSF1 even became a model protein in studies in the field of transcriptional 
response. At the same time however, the instability of the protein when recombinantly expressed and 
purified and the lack of methods to obtain structural insights on such a flexible protein lead to a loss 
of interest in the molecular characterization of its mechanisms of action. In the last years, progress 
made in methods such as mass-spectrometry or X-Ray crystallography lead to a renewal in the field. 
Unfortunately, so far, mostly HSF1s’ mechanism of activation, through the intrinsic response, the 
chaperone titration model, or in the whole organism, through the action of thermosensory neurons 
were given much thought. How the attenuation phase is regulated however, stays unknown.  
It has been known for decades that the Hsp70/Hsp40 machinery interacts with trimeric HSF1 in the 
late phase of the heat shock response, shutting its transactivational capacity down, in a negative 
feedback manner. However, reproducing this in vitro has proven to be challenging, suggesting that 
some parameters, or co-chaperones involved are still unknown to us. 
In this study, the identification of new interaction partners of HSF1 during the attenuation phase of 
the heat shock response was intended. The relatively low amount of native HSF1, combined with the 
absence of competent immunoprecipitation antibody targeted against this protein, lead us to generate 
a stably transfected cell line overexpressing a tagged version of HSF1. The identification of interaction 
partners co-immunoprecipitated with HSF1 was performed using dimethyl labelling combined with 
shotgun proteomics.  
Furthermore, the biochemical and biophysical characterization of the interaction partners identified 
alongside the impact of these novel interaction partners on the attenuation phase were investigated. 
Taken together, our findings pave the way to more investigations of these interactions, which would 
lead to a broadened understanding of the attenuation phase of the heat shock response. 
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Chapter 3. Results 
 
3.1 Establishment of a HSF1 overexpressing cell line 
 
U2-OS cells were transfected with pIRES-GFP II-CtermHA-HsHSF1, and successful transfects were 
selected with G418. Due to cell stability issues that could arise regarding to the genomic insertion locus 
of the transcription plasmid, it was decided not to generate a single clone cell line, but rather a 
heterogeneous population of different HSF1-overexpressing clones where any unexpected behavior 
ensuing from the stable transfection would be averaged out. These clones would, alongside a C-
terminus HA-tagged HSF1, express the green fluorescent protein (GFP), which would allow an 
enrichment of positive clones in the population using Fluorescent assisted cell sorting (FACS). Three 
successive sorts were performed. As control cells, U2-OS cells were transfected with pIRES-GFP II-HA, 
and selected according to the same procedure. These cells are called mock cells. 
It was established around this time that the activation of HSF1 could be concentration-dependent, i.e., 
that higher concentration of HSF1 could lead to spontaneous trimerization, in the absence of any 
cellular stress (Hentze et al. 2016). In the case of the U2-OS pIRES-GFP II-CtermHA-HsHSF1 cell line, the 
overexpression of HSF1 being under the control of a strong CMV promoter, it is possible that the 
increased concentration of HSF1 in these cells lead to the activation of HSF1. In order to verify this, the 
levels of mRNA of HSPA1A (coding for Hsp70), and of the constitutively expressed HSPA8 (coding for 
Hsc70), were assayed in the absence of heat-shock using RT-qPCR, with HPRT1 as a housekeeping gene 
for normalization (Figure 5). 
The fold increases, relative to the wild type cells, observed for both mRNAs in both cells lines suggest 
that despite a higher concentration of HSF1, which would in vitro lead to spontaneous activation, the 
transcription of the HSPA1A gene does not seem to be up-regulated. The variations observed in the 
levels of HSPA8 mRNA are actually more important than the ones observed in the levels of HSPA1A 
mRNA, even if the expression of Hsc70 is said to be independent from HSF1, hence proving that the 
amount of mRNA coding for Hsp70 in the stably transfected HSF1 overexpressing cells are similar to 
the ones in the wild type cells. 
 
 
28 
 
 
Figure 5: Relative levels of mRNA of HSPA1A (A) and HSPA8 (B). Real time qPCR was performed on 
cDNA produced from total RNA extract originated from non-stressed U2-OS WT, U2-OS HA-HSF1 and 
U2OS mock cells. The values presented represent the fold increase of the mRNA of HSPA1A (A) and 
HSPA8 (B), relative to the WT cells. HPRT1 was used as a housekeeping gene for normalization. The 
error bars represent the standard error of the mean of three replicates. 
 
Next, the amount of Hsp70 in WT and HA-HSF1 cells at 37°C and at different time points after 
temperature upshift to 42°C was determined using through immunoblotting (Figure 6). 
Consistent with the literature, Hsp70 was hardly detectable in the absence of stress in U2-OS wild type 
(WT) cells. In contract, Hsp70 was clearly detectable at 37°C in HA-HSF1 overexpressing cells. These 
cells seemed however able to resist short temperature increases, and a significant effect was only seen 
after 4 hours of heat-shock. This experiment was repeated three times with similar results, and the 
average of the band intensity for each cell line and each time interval at 42°C is presented in Figure 6C. 
This result could be explained by the fact that a larger pool of chaperone proteins could be present in 
the HA-HSF1 cells, due to concentration-dependent HSF1 trimerization, and that this larger amount of 
chaperone would be available to buffer the harmful effect of the temperature increase, up to a certain 
point. This is similar to induced thermotolerance by a short pre-heat shock.  
These two experiments show no effect of HSF1 overexpression at the mRNA level, but a clear effect at 
the protein level. In order to conclude, HA-HSF1 and WT cells were transiently transfected with a 
reporter system in which the gene for the Firefly luciferase is under the control of the promoter to the 
mitochondrial Hsp70 (mtHsp70), containing heat shock elements (HSE). 48 hours after transfection, 
cells were submitted to heat shock at 39°C and 42°C for one hour, and allowed one hour to recover 
before being harvested. This one hour recovery has the purpose of allowing the cell to translate 
produced mRNA, and to refold the already produced Firefly luciferase, which is rendered inactive at 
42°C.  Upon HSF1 activation, a HSF1 trimer should bind to the promoter upstream of the gene of the 
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luciferase, hence driving its transcription. Figure 7A shows that after one hour of heat shock at 42°C, 
WT cells display a significant expression of Firefly luciferase, indicating an activation of HSF1.  
 
Figure 6: Anti-Hsp70 Western Blot against heat-shocked cells.  U2-OS wild type (A) and U2-OS pIRES-
GFP II-CtermHA-HsHSF1 cells were submitted to a 42°C heat shock for 90 minutes, 2, 4 and 8 hours, 
and total protein extract were blotted against an anti-Hsp70 antibody. C) This experiment was 
repeated three times with similar results. An average of the intensity of the bands is shown for each 
time interval at 42°C. The error bars represent the standard error of the mean. 
 
HA-HSF1 cells however already show a basal activation of HSF1 in the absence of cellular stress, and 
do not show any further response to the two different heat shocks applied to them. In this assay again, 
HA-HSF1 cells seem to display a permanent HSF1 activation and are resistant to further heat shocks. It 
also appears that one hour heat shock at 39°C is not sufficient to trigger the heat shock response on 
U2-OS WT cells. Applying a 42°C heat shock for different time intervals on the two cell lines confirms 
the observation made in Figure 6: whereas WT cells respond as expected to a temperature increase, 
HSF1 overexpressing cells seem to be resistant to heat-shocks, and only more aggressive stresses can 
trigger a small increase in their basal HSF1 activation (Figure 7B/C).  
Higher luciferase activity is the result of a higher basal activity of HSF1, which lead to a higher 
concentration of chaperone proteins in the cell. This is consistent to the higher concentration of Hsp70 
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observed in the absence of temperature stress in Figure 6B. It is also this larger pool of chaperones 
that might prevent the cells to react as WT cells do in the case of short-length temperature increase: 
enough chaperones are present in the cytoplasm so that HSF1 can be maintained inactive, and the 
cells can be protected from proteotoxic effects. Upon very long heat shock, more heat shock proteins 
might be needed to cope with misfolded proteins, hence the increase in the signal observed in Figure 
7C. The fact that, at 37°C, no increase in HSPA1A mRNA levels but elevated levels of luciferase activity 
were noted, suggests that HSF1 might still be active for the newly brought HSE-containing promoter, 
but that something prevents bound HSF1 on the promoter of heat shock genes to start transcription. 
Altogether, these results imply that the U2-OS pIRES-GFP II-CtermHA-hsHSF1 is constitutively in the 
attenuation phase. 
 
Figure 7: Luciferase assay on U2-OS WT and U2-OS HA-HSF1 cells. HA-HSF1 (orange) and WT (blue) 
cells were heat-shocked for different length of time at different temperatures, and allowed to recover 
for one hour. The cells were then harvested, lysed, and the luminescence generated by the Firefly 
luciferase in the presence of luciferin was measured. The values are normalized with the concentration 
of total protein in lysate. A) Cells were heat-shocked at different temperatures for one hour (plus one 
hour recovery at 37°C). Two biological replicates showed a similar trend. The error bars represent the 
standard error of the mean of three technical replicates. B) and C) Cells were heat-shocked at 42°C for 
several length of time, and allowed to recover for one hour. The error bars represent the standard 
error of the mean of three technical replicates. 
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3.2 Identification of HSF1-binding proteins 
 
In order to identify binding partners of HSF1 during the attenuation phase of the heat shock cycle, anti-
HA immunoprecipitations were performed on U2-OS HA-HSF1 and on U2-OS mock cells, using anti-HA 
agarose beads. Elution from the beads was performed by incubating the beads three times with 0,2 
mg/mL HA-peptide (Figure 8). 
 
 
Figure 8: Balance anti-HA western-blot for the anti-HA immunoprecipitation. A: Crude cell extract, B: 
Resuspended pellet, C: Clarified lysate, D: unbound fraction, E F and G: Washes, H: Peptide elution, I: 
Cooked beads. 1/1000 of the total crude cell extract, pellet, lysate, unbound fraction and washes, 1/50 
of the peptide elution, and 1/5 of the cooked beads were loaded. 
 
The presence of a protein carrying a HA-tag in the crude extract confirms the expression of HA-HSF1 
in these cells. The binding of HA-HSF1 was however not complete, as some HA-tagged protein 
remained in the flow- through (Figure 8, lane D), proving the anti-HA beads were completely saturated 
with HA-HSF1. Surprisingly, two bands are seen in the peptide elution lane. This is not expected, as any 
oligomers of HSF1 (which could eventually spontaneously form through higher concentration of HSF1) 
should not be present in a SDS-PAGE gel. This could eventually be explained by the age of the Sample 
buffer used: an old sample buffer might contain non-active DTT, allowing some HSF1 to remain 
trimeric. Then peptide elution was however not complete, as some protein remained bound to the 
beads, and could only be released by cooking the beads in 2X Laemmli buffer. 
After parallel immunoprecipitation on the lysates of the two cell lines were performed, co-
immunoprecipitated were labeled with dimethyl for three replicates (peptides issued from U2-OS HA-
HSF1 cells, and peptides issued from mock cells were labeled with medium-weight dimethyl and light-
weight dimethyl respectively), and one replicate was obtained after having grown the cells in SILAC 
(Stable Isotope Labelled Aminoacid Cell culture) growth-medium for control. The medium containing 
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the heavier amino-acid was given to the cells overexpressing HSF1. In contrast to regular SILAC 
procedure, cell lysates were not mixed together before immunoprecipitation, but at a 1:1 total protein 
concentration after elution from the beads, to have similar conditions than for the dimethyl-labelling 
replicates. This SILAC pull-down was meant to control whether the same hits are found using a 
different method. In order to only select strong candidates, only potential hits with a medium/light 
ratio above two in at least two of the four replicates were considered.  
Table 1 recapitulates the identified interaction partners fulfilling these criteria.  
 
Table 1: Identification of interaction partners of HSF11.  
Category Gene Name Protein M/L Ratio 
(DML 1) 
M/L ratio 
(DML 2) 
M/L Ratio 
(DML 3) 
M/L Ratio 
(SILAC) 
Chaperones HSPA8 Hsc70 61,4 10,2 194,2 16,4 
 HSPA1A Hsp70 62,8 8,3 382 13,2 
 HSPA9 mtHsp70 10,8 74,9 24,3 9,5 
 HSPA5 Endoplasmic 
reticulum Hsp70 
4,2 0,7 11,2 4,4 
Co-chaperones BAG2 Bag2 3,1 15,9 44,5 12,5 
 BAG4 Bag4 3,7 9,1 3,6 9,9 
Carcinogenesis DMBT1 Deleted in Malignant 
Brain Tumor Protein 1 
2,0 1,9 0,8 2,6 
Transcription 
elongation 
HTATSF1 HIV-TAT Specific 
Factor 1 
- 3,0 2,4 2,3 
Chromatin 
remodeling 
SMARCD2 SWI/SNF-related 
matrix-associated 
actin-dependent 
regulator of chromatin 
subfamily D member 2 
 
 
2,6 
 
 
2,1 
 
Not 
quantified 
 
 
- 
 
The identification of molecular chaperones of the Hsp70 family is not surprising. It has been shown in 
several studies that the Hsp70/Hsp40 complex represses the transactivational capacity of HSF1, 
attenuating the heat shock response. No protein of the Hsp40 family was identified, but this could be 
due to the fact that the interaction between the J-domain protein and its substrate is transient, weak, 
and therefore that no Hsp40 was co-immunoprecipitated. The presence of the mitochondrial and of 
the endoplasmic reticulum Hsp70s are not expected, as HSF1 is not supposed to be present in those 
organelles. It is hence most likely that those protein/protein interactions happened after cell lysis, 
during the two and a half hour incubation with the anti-HA beads used for immunoprecipitation.  
                                                          
1 DML 1, 2 and 3 represent the three independent replicates analyzed with dimethyl labelling 
shotgun proteomics. 
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Besides Hsp70s, the Hsp70 co-chaperones Bag2 and Bag4 were identified in the four replicates with 
high Medium over Light ratios. Bag proteins are nucleotide exchange factors of the Hsp70 family, and 
finding them in such a screening is interesting, as co-chaperones of Hsp70 during the attenuation phase 
of the heat shock cycle are still unknown. It is however possible that Bag2 and Bag4 do not interact 
directly with HSF1, but rather through Hsp70. 
None of the other potential interaction partners identified is present in the four replicates, and their 
ratios are much lower than the ones of the hits already mentioned. The Deleted in Malignant Brain 
Tumor Protein 1 (DMBT1) was never reported to interact with HSF1, but HSF1s’ involvement in cancer 
cells metabolism has been established in many studies. The presence of proteins involved in 
transcription and chromatin remodeling is consistent with the fact that HSF1 is a transcription factor. 
Indeed, HIV-Tat Specific Factor 1 is a transcription elongation factor which also plays a role in cells that 
are not infected with HIV as well are in tissues originated from seropositive patients  (Li & Green 1998), 
and the SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D 
member 2, also known as BAF60B, is a member of the SWI/SNF complex, which is known to be a 
nucleosome remodeling complex (Lorès et al. 2010). 
The high medium/light ratios, combined with the fact that  the interactions of Bag proteins with Hsc70 
or Hsp70 through their Bag domain are already studied (Gässler et al. 2001; Xu et al. 2008; Rauch & 
Gestwicki 2014) lead us to investigate this interaction further. 
 
3.3 Bag2 and Bag4 interact directly with HSF1 
 
To confirm the interaction (direct or indirect) of Bag2 and Bag4 with HSF1, U2-OS HA-HSF1 cells are 
transiently transfected with plasmids encoding 3xMYC tagged Bag2, Bag4, or fragments of these two 
proteins, alongside an empty vector as control, and immunoprecipitation against MYC and against HA 
were performed. (Figure 9).  
As the interaction between Bag proteins and Hsp70/Hsc70 is thought to happen through their C-
terminal Bag domain, the Bag domains of Bag2 and Bag4 (respectively Bag2_BD and Bag4_BD) are also 
overexpressed. Curiously, the Bag domain of Bag4 is a one third shorter triple-helix bundle than the 
Bag domain of other Bag proteins. It should however still be functional (Briknarová et al. 2002). 
The sequences of these two proteins outside of the Bag domain are not characterized. In fact, apart 
from a predicted coiled-coil domain close to the N-terminus of Bag2, no domain structure exists for 
the N-terminal parts of Bag2 and Bag4 (respectively 108 and 374 amino-acids). Hence the whole N-
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terminal parts of the two nucleotide exchange factors are also overexpressed. From now on, these 
polypeptides will be called Bag2_NTD and Bag4_NTD. 
 
Figure 9: Co-Immunoprecipitation on U2-OS HA-HSF1 cells transiently transfected with 3xMYC-Bag2 
or 3xMYC-Bag4. 3xMYC-Bag2 (A) and 3xMYC-Bag4 (B) were transfected, and cells were harvested 48 
hours after transfection. The cell lysates were used for parallel anti-MYC and anti-HA 
immunoprecipitation. Input and precipitates (IP) were blotted against HA, to visualize HSF1, or against 
MYC, to visualize the Bag proteins. Both immunoprecipitation were repeated three times, and results 
were identical. 
 
In Figure 9A, the immunoprecipitations of Bag2 and its fragments were successful (left panel). All three 
constructs seem to interact with HSF1, as they are all co-immunoprecipitated with the latter protein 
(Figure 9A, right panel). This is actually surprising, but reveals that the Bag domain of Bag2 might be 
structurally different than the Bag domain of other Bag proteins, as suggested by Xu and colleagues 
(Xu et al. 2008). Pulling down 3xMYC-Bag2 or fractions of it, it was in our hands not possible to detect 
co-immunoprecipitated HSF1. This can be due to the fact that Bag2 was reported to be non-client 
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specific, and therefore interacting with many clients of Hsc70 (Taipale et al. 2014), hence with a lesser 
fraction of HSF1. It could also be due to different antibody-sensitivity between the anti-HA and the 
anti-MYC antibodies. In Figure 9B, it appears that Bag4_BD and Bag4_NTD are not well expressed. 
However, the immunoprecipitations were successful, and these polypeptides could be concentrated 
in the precipitates. Pulling on HSF1 through its HA tag, it is clear that HSF1 interacts with full length 
Bag4, but also with its “N-terminal domain”. There is however no band visible for the Bag domain of 
Bag4, suggesting that HSF1 does not (or only weakly) interact with the Bag domain of Bag4 (Figure 9B). 
In the reverse pull-down (MYC-IP) HSF1 co-immunoprecipitates with Bag4 full length, with Bag4_NTD 
and eventually with Bag4_BD. This last interaction is however not clear, and could be unspecific, even 
if the band seen is above background. The amount of MYC-tagged proteins seen in the input in Figure 
9A is much lower than the amount of MYC-tagged proteins detected in Figure 9B. Comparing the 
intensity of the bands corresponding to the Bag proteins pulled-down in these two experiments, it is 
likely that much more proteins should have been loaded in order to see HSF1 co-immunoprecipitated 
with                                                           ag2. 
The interactions between HSF1 and Bag2 or Bag4 were here confirmed in vivo. It is however possible 
that these interactions are indirect and happens through Hsp70/Hsc70. In order to control this, U2-OS 
HA-HSF1 cells are transiently transfected with the same constructs as previously, and anti-HA and anti-
MYC immunoprecipitations followed by a western blot against both Hsc70 and Hsp70 are performed 
(Figure 10).  
 
 
Figure 10: Anti-Hsc70/Hsp70 western blot on immunoprecipitated U2-OS HA-HSF1 cells lysates. 
Hsc70 and Hsp70 are co-immunoprecipitated with HSF1 (through anti-HA western blot) and with Bag2 
and Bag4 (through anti-MYC western blot). 
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Hsc70/Hsp70 is pulled-down alongside HSF1, confirming the interaction seen with shotgun 
proteomics. Both Bag2 and Bag4 interact as full length protein with Hsc70/Hsp70. Bag2_BD and 
Bag2_NTD alone do not seem to interact with a molecular chaperone of the Hsp70 family, as the 
intensity of the band seen is similar to the unspecific band detected in the control, when an empty 
vector is being transfected. Hence, to interact properly with Hsc70 or Hsp70, the Bag domain of Bag2 
appears not to be sufficient. On the other hand, Bag4 precipitates with Hsc70/Hsp70 as a full length 
protein, and it seems that its Bag domain alone is able to interact with the chaperone as well. 
Bag4_NTD seems to slightly interact with Hsc70 or Hsp70 as well. This could however be due to the 
fact that Bag4_NTD is rather unstructured and might therefore be a considered by the chaperone as a 
substrate. It is consequently here possible to emit the hypothesis that Bag4 interact with Hsp70 
through its Bag domain, and through HSF1 through the N-terminal part of the protein. For Bag2, it 
would be tempting to conclude the same, but our data show otherwise: Both Bag domain and N-
terminal domain are able to interact with HSF1, and it seems that only the full length protein is able to 
interact with Hsp70 in vivo. This could be explained by the structural differences between the Bag 
domains of Bag2 and Bag4. 
Next, in order to confirm these direct interactions in vitro, expressions a N-terminal Glutathione-S-
transferase (GST) fusion of Bag2, Bag2_NTD Bag2_BD, Bag4, Bag4_NTD and Bag4_BD in MC-1061 E. 
coli were made, and  GST pull-down using Glutathione agarose, in the presence or the absence of 2 
μM of purified HSF1 were subsequently performed. GST alone was expressed as a control. The N-
terminal domains of both nucleotide exchange factors were cloned as well, but their expression in MC-
1061 could not be detected. This is most probably due to the unstructured nature of those 
polypeptides, making them susceptible to protease degradation. The GST-fusion proteins were eluted 
from the Glutathione agarose using a glutathione solution, and SDS-PAGE followed by anti-HSF1 and 
anti-GST immune-blotting were subsequently performed (Figure 11). 
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Figure 11: In vitro GST pull-downs of Bag2_FL, Bag2_BD, GST, Bag4_FL and Bag4_BD. Purified HSF1 
was loaded in the middle of the gel as a control. MC 1061 bacterial lysates were incubated with 20 μL 
of Glutathione agarose 4B, and, when indicated, with 2 μM of purified HSF1. This experiment was 
repeated twice with similar results. 
 
In this experiment, the interactions seen can only be direct interactions, as Hsp70 is missing in the 
cytoplasm of E. coli. It appears that both Bag2_FL and Bag4_FL interact as GST fusion with HSF1. When 
GST was expressed alone, a slight HSF1 band can be seen. This is most probably negligible, as GST was 
strongly expressed compared to the GST fusion of Bag2 and Bag4, and the co-precipitated HSF1 
observed much more abundant. It is hence safe to suppose that the HSF1 band seen in the “GST +HSF1” 
lane is the result of not properly washed beads. Therefore, Bag2 and Bag4 directly interact with HSF1, 
and not through a chaperone of the Hsp70 family. For both proteins, it seems that the Bag domains 
are also able to interact with HSF1. This was already seen in vivo for Bag2, but not in the case of Bag4. 
This could be explained by the fact that in presence of Hsc70/Hsp70, Bag4_BD would preferably 
interact with the molecular chaperone. In the absence of the latter, the Bag domain of Bag4 could then 
interact with HSF1 in a similar manner than Bag2_BD. 
 The full-length version of Bag4 was not well expressed and partly degraded, as the GST-fusion 
detected through immuno-blotting was much lighter than it should have been. In fact, it is barely bigger 
than GST alone. Nevertheless, it seemed that this shortened version of Bag4 was still able to interact 
strongly with HSF1, confirming the interaction of Bag4’s NTD with HSF1.  
38 
 
Bag2’s role as a nucleotide exchange factor of Hsp70 is established, though not quantitatively (Dai et 
al. 2005; Xu et al. 2008; Rauch & Gestwicki 2014), but Bag4 was left out of many studies on the 
nucleotide exchange activity of members of the Bag protein family. 
 
3.4 In vitro characterization of Bag2 and Bag4 
 
3.4.1 Purification of Bag2, Bag4 and Hsc70. 
 
Bag2 full length, Bag2 Bag domain, Bag4_BD and Hsc70 were expressed as N-terminal 6xHis-SUMO-
fusion in BL21(DE3) RosettaTM E. coli and purified as described in chapter 5. The purification of Bag4 
full length was attempted, but obtaining the full length protein was not met with success, as the 
suspected unstructured N-terminus of the protein was protease sensitive. Figure 12 presents the 
purification balance for each protein purified. 
The challenge encountered in purifying Bag2_FL was the fact that even a His-tag depleted Bag2 was 
still able to interact with the Nickel beads. To overcome that issue, Nickel resin was saturated with 
Ulp1 SUMO-protease beforehand, and the digestion was performed on column, for 2 hours. This way, 
Bag2 could not interact with the nickel ions, and a mixture containing Bag2 and the free SUMO was 
generated. Gel filtration using a Superdex 75 gel filtration column was performed as a last step, 
allowing the separate Bag2 from the free SUMO, and additional impurities that were bound to the 
Nickel column in an unspecific manner. 
The Bag domain of Bag2 was purified according to Xu and colleagues (Xu et al. 2008), and a Superdex 
Peptide 10/300 GL was used instead of the Superdex 75 they used. The initial steps were almost 
identical as for Bag2_FL, with Nickel affinity purification, and cleavage of the SUMO tag using the Ulp1 
protease. 
The purification of the Bag domain of Bag4 did not required any additional step after SUMO cleavage, 
besides two extra Nickel affinity purification, in order to bind Ulp1, and free SUMO. As a matter of fact, 
the removal of Ulp1 and free SUMO proved unsuccessful after the second Nickel affinity purification, 
and a third one was necessary.  
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Figure 12: Purification of recombinant Bag2_FL (A), Bag2_BD (B), Bag4_BD (C) and Hsc70 (D).  
M: Molecular weight marker (from top to bottom: 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 
35 kDa, 25 kDa, 15 kDa, 10 kDa), A1: Crude lysate, A2: Clarified lysate, A3: Flow-through Nickel beads, 
A4: Wash with lysis buffer, A5: Wash with high-salt buffer, A6: Imidazole elution from the Nickel beads, 
A7: After on column Ulp1 digestion, A8: fractions 25 and 26 of S75 gel filtration, A9: Fraction 27 of S75 
gel filtration; B1: Imidazole elution from Nickel beads, B2: After overnight Ulp1 digestion, B3 to B8: 
fractions 16 to 21 after Superdex Peptide 10/300 GL gel filtration; C1: Crude lysate, C2: clarified lysate, 
C3: Flow-through Nickel beads, C4: Wash with lysis buffer, C5: Wash with high-salt buffer, C6: Imidazole 
elution from the Nickel beads, C7: After overnight Ulp1 digestion, C8: After second Nickel affinity 
purification, C9: After third Nickel affinity purification; D1: Crude lysate, D2: clarified lysate, D3: Flow-
through Nickel beads, D4: Wash with lysis buffer, D5: Wash with high-salt buffer, D6: ATP wash, D7: 
Wash with lysis buffer, D8: Imidazole elution from the Nickel beads, D9: After buffer exchange, D10: 
After overnight Ulp1 digestion, D11: After second Nickel affinity purification, D12: After Res Q anion 
exchange chromatography. 
 
The first steps of the purification of Hsc70 differed from the three other purifications described in this 
work, as an ATP-wash was performed in order to induce substrate release of substrate that could have 
been bound by Hsc70. After additional wash, elution was performed with an Imidazole containing 
buffer, as previously. Moreover, anion exchange chromatography was performed at the very end of 
the purification.  
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3.4.2 Secondary structure analysis of Bag2 and Bag4 
  
Before using the proteins previously purified in in vitro biochemical assays, it was necessary to make 
sure that they were well-folded. As the Bag domains of both Bag2 and Bag4 were reported to be α-
helical, the secondary structures of Bag2 and Bag4_BD are obtained through far-UV circular dichroism 
(CD) spectroscopy. This method is based on the interactions between polarized light and chiral 
molecules and is one of the best method to determine alpha helicity. Proteins, mostly through the 
carbon atom of the peptidic bond, are chiral macro-molecules. It is therefore possible to obtain an idea 
of the α-helical, β-sheet, or random coil composition of a protein. The CD spectra of Bag2, Bag4_BD, 
and Bag2_BD are displayed in Figure 13. 
With maxima at 195 nm, and two minima at respectively 208 and 222 nm, both Bag2_FL and Bag4_BD 
are mostly α-helical. This is to be expected for the latter protein, as it was reported than a canonical 
Bag domain is made of a triple α-helix bundle. It is therefore possible to assume than Bag4_BD is 
properly folded, and hence that it should be active for in vitro assays. The Bag domain of Bag2 makes 
up almost half of the full length protein, and was also reported to be made of  three α-helixes. The 
remaining 12.3 kDa of the protein contain a short predicted coiled-coil domain which is also made of 
α-helixes.  
The Bag domain of Bag2 is, according to Xu and colleagues, made of three α-helix (Xu et al. 2008). 
Hence, the first CD spectrum, obtained directly after purification, was not surprising, displaying a well-
defined α-helical pattern (Figure 13C, right panel). However, snap-freezing the protein and thawing it 
for subsequent experiments revealed a different spectrum (Figure 13C, right panel), as the 195 nm 
peak, characteristic of α-helixes became a rather flat-line. Since random coil spectra exhibit a minimum 
at 195 nm, it is possible that the flat line with a θ value roughly equal to 0 deg.cm².dmol-1 is actually an 
average of α-helical maximum and random-coil minimum. Moreover, the 208 nm minimum was lost, 
and replaced by a 215 nm minimum, characteristic of β-sheets, implying an eventual aggregation of 
the protein after thawing. This allow us to conclude that Bag2_BD cannot be frozen and still maintain 
its activity when thawed. 
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Figure 13: Circular dichroism spectra of Bag2_FL (A), Bag4_BD (B) and Bag2_BD (C). In C, the left panel 
represents the CD spectrum of Bag2_BD directly after purification. The right panel is the CD spectrum 
of the same protein, after one freeze-thaw cycle.  
 
 
3.4.3 Thermal stability of Bag2 and Bag4 
 
In order to establish how these proteins can be handled for in vitro experiments, their thermal stability 
was assayed. Thermal stability can be assayed using CD by following the changes in CD-value while 
increasing temperature. The single wavelength of 222 nm was chosen, and the signal at that 
wavelength is recorded at each temperature. A  gradient of 20°C/hour, ranging from 10°C to 90°C was 
performed on each of the three Bag proteins purified (Bag2_FL, Bag2_BD, and Bag4_BD).  
The denaturation curves are presented on Figure 14. From these results, it is clear that Bag2 full length 
is folded and stable until 40°C, temperature after which it starts to unfold. The process seems to be in 
two steps: one sharp increase in CD values happening between 50 and 60 °C, and a shallower, linear 
increase from 60°C to 90°C (Figure 14 A). The denaturation of the Bag domain of Bag4 appears to follow 
a sigmoidal pattern, with shallow signal change from 10°C to 50°C, indicating non-cooperative 
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unfolding. This is followed by a steeper increase in CD values up to 75°C. Slower increase in the CD 
signal up to 90°C finishes the recording. Bag4_BD hence seems to start unfold already at low 
temperature, hinting that this protein would not be completely stable. It is however not the complete 
protein, and a stabilization of the Bag domain by parts of its N-terminal sequence could be considered 
(Figure 14 B). Bag2_BD, which was assumed to be aggregated after thawing displays an almost linear 
denaturation curve, confirming the idea that this protein is unfolded, aggregated, and might therefore 
not be active (Figure 14 C).  
The sharp increase in CD value observed in Figure 14 A suggests high cooperativity in the unfolding 
mechanisms. According to Xu and colleagues, Bag2 forms homodimers that can in vivo interact with  
 
Figure 14: Temperature denaturation of Bag2_FL (A), Bag4_BD (B) and Bag2_BD (C). The curves 
display the CD value at 222 nm for each temperature of the scan. The curve for Bag2_BD was obtained 
from a frozen aliquot. 
 
several Hsp70s close to each other (Xu et al. 2008). If one admits this hypothesis, it could very well be 
that homodimers of Bag2 are present in the sample measured here, and that the steep CD values 
increase actually represents some unfolding leading to monomerization of the protein. From there, 
the denaturation appears to be linear, as it is the case for the Bag domain of Bag2, which is most 
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probably already misfolded. It is however unknown to us whether Bag2 forms homodimers, the 
structure published by Xu and colleagues being of its Bag domain only. 
Taken together, these data tell us that in vitro assays involving Bag2_FL can be performed at 
physiological temperature, and lower. The Bag domain of Bag4 becomes less stable at temperatures 
above 30°C. Therefore, no in vitro assays can be performed at a temperature above 30°C. Finally, 
purified Bag2_BD starts to unfold at 10°C, indicating that it is not stable under in vitro conditions. 
 
3.4.4 Bag2 and Bag4 act as nucleotide exchange factors of Hsp70 
 
As mentioned earlier, Bag2 is not well characterized. For example, no rates of nucleotide exchange 
dependent on the concentration of Bag2 have been determined. In addition, Bag4 was always left out 
comparison studies between the different proteins of the Bag family. As no full length Bag4 was 
available, its Bag domain will be used, and compared to Bag2. 
In order to investigate the influence of the Bag proteins on nucleotide exchange capacity of Hsc70 and 
Hsp70, ADP release stimulations by Bag2 and Bag4_BD are measured with stopped-flow 
instrumentation. The reaction will be followed by using the synthetic ADP analog MABA-ADP, which 
was shown to have similar kinetic property as its natural counterpart in the case of Bag1 (Gässler et al. 
2001), and of the E. coli Hsp70-like chaperone DnaK (Theyssen et al. 1996). Since fluorescence intensity 
of MABA-ADP at 420 nm is strongly increased when it is bound to Hsp70, its release can then be 
followed by a decrease in fluorescence (Figure 15 A). 
This decrease in fluorescence (Figure 15 A) was fitted using a single exponential decay function, and 
the MABA-ADP.Hsp70/Hsc70 complex dissociation coefficient (koff) was plotted against the 
concentration of nucleotide exchange factor (Figure 15 B). 
The Bag domain of Bag2 did not stimulate the release of MABA-ADP, as increasing concentration of 
Bag2_BD did not have any effect on the value of koff. This observation indicates that the Bag domain 
of Bag2 was inactive, consistent with the conclusions drawn from the CD spectra. Bag2 full length 
however does have an effect on the dissociation of the complex between MABA-ADP and 
Hsp70/Hsc70. In addition, it appears that Bag2’s stimulation of nucleotide exchange is much stronger 
on Hsc70 than on Hsp70. This is interesting, as it was shown by Gässler and colleagues that Bag1-M 
stimulated both Hsp70 and Hsc70 to a similar degree, with a slightly stronger stimulation of Hsp70 
(Gässler et al. 2001). The Bag domain of Bag4 turned out to be a much more efficient nucleotide 
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exchange factor than Bag2, but similar to Bag2, it stimulates nucleotide exchange more efficiently in 
Hsc70 than in Hsp70. This weaker effect of Bag2 could be due to the different nature of its Bag  
 
Figure 15: Stimulation of ADP release from Hsp70/Hsc70 by Bag2 and Bag4_BD. Hsp70 and Hsc70 
were both incubated with MABA-ADP for 30 minutes at 30°C, to allow saturating binding of the 
nucleotide analog to the chaperone before the nucleotide exchange factor is injected with the 
stopped-flow device. A) Dissociation of the MABA-ADP.Hsc70 complex after addition of an excess of 
unlabeled ATP in the absence (green) and presence (blue) of Bag4_BD (2.5 μM). B)  koff values for 
MABA-ADP complexes with Hsp70 and Hsc70 as indicated in the presence of increasing concentration 
of Bag protein. 
 
domain, not being the canonical triple helix bundle. It is however hard to draw any conclusion 
regarding to the stronger stimulation of Bag4 in relation to Bag2, as only the Bag domain of Bag4 was 
used, and not the full length protein. Moreover, it was shown that the Bag domain of Bag1-M is a more 
active nucleotide exchange factor than its full length version (Gässler et al. 2001).  
To conclude, purified Bag2 and Bag4_BD clearly are nucleotide exchange factor of Hsp70. 
Unfortunately, the concentration obtained after purification of the two proteins did not allow to titrate 
the Bag proteins to higher concentrations to reach saturation of the dissociation rate. 
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3.4.5 Bag2 and Bag4 increase luciferase refolding rates 
 
 
Nucleotide exchange factors increase the rates of ADP release. In the theoretical work cycle of Hsp70s, 
the release of ADP allows the binding of a new molecule of ATP, which in turn decreases the affinity of 
Hsp70 for its substrate. Hence, release of ADP leads to substrate release. Up to a certain concentration, 
the presence of a nucleotide exchange factor should therefore accelerate the rates of refolding of 
Hsp70s’ substrate. Passed a certain concentration of NEF, the effect could be negative on substrate 
refolding, as the latter one would be released before having attained a conformation that refolds 
efficiently. 
To verify the cooperation of the purified Bag proteins with an Hsp70-family chaperone in a classical 
chaperone function, the model protein Firefly luciferase was used. Firefly luciferase unfolds at 42°C, 
but can be refolded in the presence of Hsp70 and a J-domain protein co-chaperone. The addition of a 
nucleotide exchange factor up to a certain concentration should enhance the reaction. Since Hsc70 
was more stimulated than Hsp70 by both nucleotide exchange factors tested, this chaperone will be 
used for refolding heat-denaturated Firefly luciferase. As Bag2 and Bag4_BD were not very 
temperature-stable in vitro, Firefly luciferase was first denaturated for 10 minutes at 42°C in the 
presence of Hsc70 and the J-domain protein Hdj1. The Bag proteins were added after return at 30°C 
for the refolding reaction. At regular time intervals, the activity of luciferase was assayed. The influence 
of Bag2 and of Bag4_BD on luciferase refolding by Hsc70 is presented in Figure 16. 
At all concentrations tested, Bag4_BD (Figure 16 A) and Bag2 (Figure 16 B) are positively affecting the 
kinetics of refolding, as it can be observed when compared with the refolding kinetics in the absence 
of nucleotide exchange factor (Hsc70 + Hdj1, black dots). The kinetics were also measured in the 
presence of Bag2_BD (Figure 16 C), but luciferase refolding was actually slower in the presence of the 
nucleotide exchange factor (for the concentration tested) as in its absence. This is an additional 
evidence that the purified Bag2_BD is not active. Being misfolded, it could actually act as a substrate 
of Hsc70, competing with Luciferase for binding to Hsc70. During the time in which the chaperone 
might be trying to refold Bag2_BD, luciferase might aggregate, hence preventing any further refolding. 
At 4 μM of Bag2_BD, it is possible that most of the NEF is aggregated, hence allowing the refolding of 
luciferase to be comparable to the one observed in the absence of nucleotide exchange factor.  
Comparing the refolding after an incubation time of 60 minutes, for the different concentrations of 
Bag protein tested, no significant difference between Bag2 and Bag4_BD are noticeable (Figure 16 D). 
The same is observed when comparing the initial rates of refolding (Figure 16 E). This is interesting, as 
Bag4_BD appeared to be much more efficient at stimulating ADP-release than Bag2. However, it is 
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possible that a too fast ADP-release would lead to a premature substrate release, hence prolonging 
the number of Hsp70 cycles needed for efficient luciferase refolding. The curves representing the 
refolding after 60 minutes as a function of the concentration of Bag protein (Figure 16 D), and the 
curves representing the initial rates of refolding against the concentration of Bag protein (Figure 16 E) 
 
 
Figure 16: Refolding of heat-denaturated luciferase by Hsc70, Hdj1 and either Bag2 or Bag4_BD. A) 
B) and C), refolding kinetics for different concentrations of Bag4_BD (A), Bag2 (B) and Bag2_BD (C). D) 
Percentage of refolded luciferase after 60 min of refolding at 30°C in the presence of increasing 
amounts of nucleotide exchange factor. The refolding were normalized to the activity of luciferase 
before denaturation. E) Initial refolding rates for increasing concentrations of Bag protein. The error 
bars represent the standard error. The “Hsc70 + Hdj1” kinetics were always measure anew, in parallel 
to each nucleotide exchange factor: the values might therefore differ.  
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curiously follow very similar trends, this implying that the levels of refolding after one hours are 
dependent on the initial rate of reaction, which in turn depends of the concentration of nucleotide 
exchange factor. 
Bag2 and the Bag domain of Bag4 are both able to act as a nucleotide exchange factor, and, through 
this role, can have a positive role on the rates of luciferase refolding. It is therefore safe to postulate 
that the full length Bag4 would have similar effects on both ADP-release and luciferase refolding, even 
if the numerical values obtained are certainly different. The role that both proteins play while 
interacting with HSF1 can be independent from this role as nucleotide exchange factor, but the fact 
the Bag2 and Bag4 were found interacting with HSF1 alongside Hsp70 and Hsc70 could be a hint on 
their role during the attenuation phase of the heat shock response. 
 
3.5 Bag2 and Bag4 are positive regulators of the heat shock response 
 
Bag 2 and Bag4 are both able to accelerate the rate of luciferase refolding in vitro by facilitating the 
release of ADP, leading to binding of ATP and, through the subsequent conformation changes, to the 
release of Hsp70s’ substrate. Earlier in this work, it was shown that both Bag2 and Bag4 interact in vivo 
with HSF1, most probably during the attenuation phase of the heat shock cycle. Transposing what is 
known about nucleotide exchange factors of Hsp70, it would be logical to think that Bag2 and Bag4 
stimulate the release of HSF1 from Hsp70, or its constitutively expressed family member Hsc70. In 
analogy to yeast HSF1 which is constitutively trimeric, and repressed by binding of Hsp70, stimulation 
of the dissociation of Hsp70 from HSF1 should stimulate the heat shock response.  
To verify whether this hypothesis describes the in vivo reality, Bag2, Bag4, both of their N-terminal 
domains, alongside the Bag domain of Bag4 were cloned into a mammalian expression vector, and 
transiently transfected into U2-OS WT cells. Due to its inactivity in vitro, the Bag domain of Bag2 was 
not included in this experiment. An empty vector was transfected as a control. 
In addition to the Bag expressing vector, a dual luciferase reporter gene vector was simultaneously co-
transfected. This vector would express Renilla luciferase, which gene is under the control of a 
constitutively activated promoter, and Firefly luciferase, under the control of the promoter of the 
mitochondrial Hsp70, hence which expression is dependent on the activation of HSF1. Renilla 
luciferase and Firefly luciferase has a different substrates, respectively called coelenterazine and 
luciferin. Firefly luciferase was measured first, followed by injecting coelenterazine in a Firefly 
Luciferase quenching buffer and subsequent Renilla luciferase measurement. This prevented any 
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background luminescence of the first luciferase when measuring the activity of the second.  In this 
experiment, the luminescence generated by Renilla would be used to normalize the Firefly signal, 
which can be dependent on the transfection efficiency, and the amount of cells lysed. 
 
 
Figure 17: The dual-luciferase assay. U2-OS cells were transfected with a single vector containing the 
genes of both luciferases. Renilla luciferase is constitutively express, whereas Firefly luciferase is only 
expressed through binding of trimeric HSF1 to its promoter. The cells were lysed using Passive Lysis 
Buffer (Promega), and Firefly luciferase activity was measured first, by adding luciferin dissolved in the 
F. luciferase appropriate buffer. Its activity was then quenched by adding the R. luciferase assay buffer 
(containing colenterazine), in which F. luciferase is not active. 
 
Each batch of dual-transfected cells were split into six different groups 24 hours after transfection, and 
cells were heat-shocked at 42°C for several time intervals. After each heat shock, the cells were allowed 
to recover for one hour, so that the heat-denaturated luciferase could be refolded into its native state. 
The cells were then lysed, and the luminescence generated by both luciferases was measured. Figure 
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18 displays the heat shock response level for each Bag construct transfected, and each duration of heat 
shock. 
 
Figure 18: In vivo effect of Bag2 and Bag4 overexpression in U2-OS cells during heat shock at 42°C. 
A) Bag2 and Bag4 (full-length proteins and fragments) are transiently overexpressed in U2-OS cells, 
which are in turn heat shocked at 42°C for several length of time. On the y-axis, the ratio between the 
luminescent signals emitted by the Firefly luciferase and Renilla Luciferase are displayed. The x-axis 
represents the duration of the different heat shocks to which the different batches of transfected cells 
were submitted. B) Zoom in on the fragments of the fragments of Bag2 and Bag4. The value displayed 
are the average of three independent biological replicates. The error bars represent the standard error 
of the mean. 
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The behavior of control cells, which were transfected with an empty vector is quite expected: the ratio 
between the signals of the two luciferases goes up, meaning an increase in the amount of Firefly 
luciferase synthetized in the cells. This is due to the activation of the heat shock response, due to the 
heat-induced trimerization of HSF1. After four hours, the ratio starts to decrease, reflecting the 
attenuation phase. Indeed, enough molecular chaperones were produced during the first hours of heat 
shock to cope with proteotoxic damage, and the negative feedback regulation happens. 
When Bag2 and Bag4 are overexpressed, the ratios of the two signals are much stronger, even before 
the cells were submitted to heat shock. Upon heat shock, the ratios increases, as HSF1 trimerizes and 
binds to the promoter upstream of the gene coding for the Firefly luciferase, hence boosting its cellular 
concentration. The concentration of Renilla luciferase is expected to stay constant. After reaching a 
maximum at two hours of heat shock, both ratios decrease to come back to values similar to their 
levels prior to stress. This shows that the overexpression of these two nucleotide exchange factors are 
positive regulators of the heat shock response. Curiously, it appears that Bag4 have a stronger effect 
on the heat shock than Bag2. Its Bag domain was also more performant at stimulating the ADP-release 
than the full length Bag2. Maybe Bag4 is altogether a better nucleotide exchange factor of Hsp70 than 
Bag2.  
Earlier in this work, it was shown that it was the N-terminal domain of Bag4 that was interacting with 
HSF1 in vivo, and that both Bag domain and N-terminal fragment of Bag2 were able to interact with 
HSF1. It was also shown that the Bag domain of Bag4 could act as a nucleotide exchange factor of 
Hsp70 when purified on its own. Interestingly, when cells where fragments of both Bag2 and Bag4 are 
overexpressed show similar behavior between each other during heat shock (taking in account the 
standard error) Furthermore, the values of the dual luciferase ratios obtained when transfecting 
fragments of Bag proteins (Figure 18B) are barely higher than the ratios obtained for the control cells, 
suggesting that fragments of these two nucleotide exchange factors are incapable to influence the 
heat shock response on their own through stimulation of HSF1 release from Hsp70. The slight increase 
observed (when compared to control cells) might be caused by aggregation of the overexpressed 
proteins which can be misfolded. These aggregates could be titrating Hsp70 away from trimeric HSF1, 
thereby leading to a small increase in F. luciferase synthesis.  It is hence possible to postulate that in 
order to stimulate the release of HSF1 from Hsp70/Hsc70, Bag proteins need both their Bag domain 
and their N-terminal domain, implying a specificity of these two proteins in this role. 
A shift in the maximal intensity ratios for the cells transfected with the two full-length proteins was 
observed when compared to control cells, reflecting an earlier entry into attenuation phase. This can 
easily be explained by the fact that stronger heat shock response (visualized by a relatively stronger 
Firefly luciferase-generated luminescence) would issue in more molecular chaperones synthetized in 
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a shorter time, and therefore a faster and more efficient protection from and repair of cell damage. 
Hsp70 and Hsc70 would then be earlier available for interacting with HSF1, hence decreasing its 
transcription capacity. 
Finally, the fact that the heat shock response is already activated before the start of the cellular stress 
implies the existence of trimeric HSF1 in the absence of any stress. It is already known that HSF1 have 
roles other than triggering the heat shock response, and it was suggested that human HSF1 might 
constantly be activated, attenuated by Hsp70 and then monomerized, thus maintaining the 
transcription of genes with HSE-containing promoters at a low level (Hentze et al. 2016). In the case of 
Bag2 and Bag4 overexpression, the release of trimeric HSF1 by Hsp70 would displace this equilibrium 
between inactive and active HSF1 towards DNA-bound trimer, with the consequence of a constitutive 
heat shock response. 
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Chapter 4. Discussion 
 
The aim of the current work was to identify and to characterize new interaction partners of HSF1 during 
the attenuation phase of the heat shock response. Several studies in the late 1980’s and the early 
1990’s identified Hsp70 as negative regulator of the transcriptional capacity of HSF1 (Mosser et al. 
1988; Abravaya et al. 1991a; Baler et al. 1992). It was naturally postulated that Hsp70 represses HSF1 
in concert with a co-chaperone of the Hsp40 family, which one is unknown, as more than 40 J-domain 
proteins have been identified in human cells. It is also disputed whether other chaperones or co-
chaperones play a role in HSF1 attenuation. 
In this work, a human cell line supposedly constitutively in the attenuation phase of the heat shock 
cycle was established, by stably overexpressing HSF1. This cell line was characterized by a slightly 
elevated basal pool of heat shock proteins, and by a certain resistance to further heat shocks applied 
to them. These cells were used to perform a screening for proteins interacting with HSF1, and the two 
molecular chaperones Hsp70 and Hsc70 were identified, alongside with Bag2 and Bag4, two nucleotide 
exchange factors of Hsp70/Hsc70. The interactions between HSF1, Bag2 and Bag4 were confirmed in 
vivo, and in vitro, and evidence that this interaction is direct was provided. Moreover, it was shown 
that in the case of Bag4, the interaction was taking place through the N-terminal domain of the protein, 
its Bag domain interacting with Hsp70 or Hsc70. In the case of Bag2, it was less clear, as it appeared 
that both Bag domain and N-terminal fragment can interact on their own with HSF1.  
Bag2, and the Bag domain of Bag4 were then purified, and circular dichroism measurement showed 
that these two polypeptides mostly have a α-helical secondary structure, as Bag domain are known to 
be. Both proteins could stimulate ADP-release by Hsp70 and Hsc70, and increase the refolding rates of 
heat-denaturated luciferase. Finally, overexpressed in human cells, Bag2 and Bag4 could increase 
dramatically the heat shock gene transcription in the absence and presence of thermal stress, most 
probably by leading Hsp70 to release trimeric HSF1. Although the Bag domain of Bag4 was active in 
vitro, clear evidences were provided in this work that only the full length Bag2 and Bag4 are able to 
tune up the heat shock response. 
 
4.1 Implications of the eventual interaction partners identified 
 
The ten hits that were detected above the threshold chosen for the screening could be seen as a 
relatively small group of potential interactors of HSF1, even during the sole attenuation phase of the 
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heat shock response. It has however to be taken in account that the criteria chosen were very 
restrictive, as the medium/light ratios had to be over 2 in at least two of the four replicates. Hence, 
some unspecific partners were ruled out from the beginning. It was also surprising that many proteins 
that were previously reported to interact with HSF1 were not found in this screening. Hsp90 was 
reported to inhibit the transactivation of HSF1 in Xenopus oocytes (Ali et al. 1998) and Guo and 
colleagues suggested that Hsp90 forms a complex with FKBP52 and p23 to suppress the transcriptional 
activity of trimeric HSF1 in HeLa cells (Guo et al. 2001). The latter interaction was however only seen 
after DSP-crosslinking, hinting its transient nature. During the immunoprecipitation performed in this 
work, the incubation times with the anti-HA antibody were more than twice as long as in the pull-
downs performed by Guo and colleagues. Moreover, in this work, it is highly possible that the stringent 
washes dissociated some of the weaker interactions. 
 An interaction between HSF1 and Replication protein A (RPA) was shown to facilitate the access of 
trimetric HSF1 to the promoter of HSPA1A by recruiting the histone chaperone FACT (Fujimoto et al. 
2012). In this study, neither RPA nor FACT were found interacting with HSF1. However, in the U2-OS 
HA-HSF1 cell line, it would be expected that the promoters of heat shock are already fully accessible, 
as the transfection of the pIRES vector was stable, and HSF1 had been overexpressed for several 
months by the time of the immunoprecipitation. SMARCD2, a member of the SWI/SNF complex, 
responsible for nucleosome remodeling was however identified interacting with HSF1 in this study. 
The SWI/SNF complex was suggested to cooperate with HSF1 to un-pause the RNA polymerase II at 
the promoter of HSPA1A (Brown et al. 1996; Brown et al. 1998). According to Brown et al, the RNA pol 
II would be paused on the promoter of Hsp70, this pause being due to the nucleosome density around 
that gene. A combination of trimeric HSF1, a transcription elongation factor, and the SWI/SNF complex 
would then disrupt the nucleosome organization and relieves the RNA polymerase (Brown et al. 1998; 
Sullivan et al. 2001; Corey et al. 2003). In the present work, a transcription elongation factor, HIV-Tat-
Specific Factor 1 was also identified as a potential interactor of HSF1, though only in three of the four 
replicates. Therefore, SMARCD2 and HIV-Tat-SF1 could be involved in chromatin rearrangement at the 
promoter of heat shock genes. 
The putative interactors of HSF1 Bag2 and Bag4 identified in the screening performed in this work were 
already identified by Taipale and colleagues in a LUMIER screening involving the Hsp70 and Hsp90 
chaperones (Taipale et al. 2014). Indeed, this study reports strong interactions between HSF1 and 
Bag1, Bag3, Bag5, and weaker interactions with Bag2 and Bag4. Another work reported Bag3 
interacting directly with HSF1 in stressed and non-stressed cells, and affecting the shuttling of HSF1 
out of the nucleus (Jin et al. 2015). Overexpression of Bag3 was shown to decrease the concentration 
of nuclear HSF1, in accordance to the fact that among all the Bag proteins, Bag3 is the only one which 
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expression is HSF1-dependent (Pagliuca et al. 2003; Franceschelli et al. 2008; Rosati et al. 2009). An 
up-regulation of Bag3 would then participate in the reduction of the intensity of the heat shock 
response, by reducing the amount of HSF1 present in the nucleus, hence decreasing the chance of re-
binding to DNA. Neither Bag2 nor Bag4 were reported so far to play a role in the heat shock response, 
as Bag2 was reported to be a general non-client-specific cofactor of Hsp70, and Bag4 was shown to 
strongly interact with three central components of the mRNA decapping complex (Taipale et al. 2014). 
Although interactions between Bag2, Bag4 and HSF1 were already detected with LUMIER assay 
(Taipale et al. 2014), this assay cannot distinguish between direct and indirect interactions. In this 
work, evidence of a direct interaction was shown. 
 
4.2 Bag2 and Bag4 interact with HSF1 and Hsp70 
 
In this study, the interaction between HSF1 and the two nucleotide exchange factors Bag2 and Bag4 
was confirmed. Indeed, it was possible to detect both Bag2 and Bag4 when pulling on HSF1. Moreover, 
it appeared very clearly that Bag4 interacts with HSF1 through its N-terminal fragment, and with 
Hsc70/Hsp70 through its Bag domain. The N-terminal domain of Bag4 is composed of 67 Proline, 44 
Glycine and 33 Tyrosine (out of a total of 378 amino-acids). Therefore it can be expected that it has 
little structure, and that it is relatively hydrophobic, even if these tyrosine are spread all over the 
protein. This could explain why the N-terminal fragment of Bag4 co-immunoprecipitated with Hsc70, 
as it could be considered as a good chaperone substrate. This lack of structure also marks the protein 
as being quite instable, thus explaining the difficulties encountered when purifying it from E. coli.  
Immuno-precipitations using an anti-MYC antibody (so with Bag2 or Bag4 as target) revealed that HSF1 
could be co-immunoprecipitated with the full length Bag4, its N-terminal domain, and its Bag domain 
to a lower extend. This last interaction is however unexpected. Pulling on Bag2 did not enrich HSF1, 
but this could be explained with the fact that Bag2, being a general non-substrate specific nucleotide 
exchange factor (Taipale et al. 2014), might interact with many different substrates of Hsc70 (or 
Hsp70), only a fraction of which being HSF1. The interactome of Bag4 in contrast was reported to be 
related to the mRNA decapping mechanism, and was found localized in P-bodies (Taipale et al. 2014). 
Thus, a much more substrate-specific nucleotide exchange factor could enrich HSF1 more efficiently 
than a general one, such as Bag2. 
Bag2 appeared to interact with HSF1 through both its Bag domain and its N-terminal fragment. It was 
proposed that the Bag domain of Bag2 interacts with Hsp70s’ substrate, and favors its binding to the 
SBD of the (Xu et al. 2008). In the present work, this interaction between Bag2_BD and HSF1 may have 
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been seen, in addition to an interaction through Bag2_NTD, but the model proposed by Xu and 
colleagues does not make much sense, as it is unlikely that Bag2 acts first as a J-domain protein, 
providing its substrate to the chaperone, and then as a NEF. In addition, only the full-length Bag2 
seemed to bind Hsc70. This was surprising, as Xu and colleagues published the structure of the Bag 
domain of Bag2, dubbed Brand New Bag domain (BNB), as a dimer, and as a complex with the 
Nucleotide binding domain of Hsc70 (Xu et al. 2008). The complex showed some conformational 
changes proposed to lead to release of ADP. The conformational changes observed are similar but not 
as extensive as those induced by Bag1 and Hsp110.  They also attested of the activity of their purified 
full length Bag2, but only of the activity of the Bag domain of the murine Bag2. No mention of the 
activity of human Bag2_BNB was made. In this study, the purified Bag domain of human Bag2 was not 
active in some ADP-release experiments, and seemed to be aggregated after one freeze/thaw cycle.  
In their model, Xu et al present the structure of a homodimer of Bag2, bound to two different Hsc70. 
It is possible that a dimer of Bag2 interacts with two neighboring Hsc70, which in turn interact with 
two different transactivation domains of a HSF1 trimer. This would lead to a simultaneous and hence 
more efficient nucleotide exchange from the chaperones interacting with HSF1. 
The in vitro GST-pull-downs performed in this work confirmed the direct interaction of Bag2 and Bag4 
with HSF1. Indeed, the absence of human Hsp70 or Hsc70 in E. coli renders the interaction of HSF1 
with the GST-tagged Bag protein doubtlessly direct. It was however quite surprising that the two Bag 
domains were also capable of interacting with HSF1. In the case of Bag2_BD, this would confirm what 
was seen in vivo, but also the observations made by Xu et al. However, no in vivo interaction between 
the 70 kDa molecular chaperone and Bag4_BD was detected in the present work. It could be the case 
that Bag4_BD interacts with HSF1 in a similar manner than Bag2_BD, but this would be rather unlikely, 
as the two Bag domains have different structures, the Bag domain of Bag4 displaying a structure close 
to the canonical Bag domain, even if shorter (Briknarová et al. 2002). It could be possible that in 
absence of molecular chaperone of the Hsp70 family, the α-helical structure of Bag4_BD interacts in a 
non-physiological manner with HSF1, by forming coiled-coil structures for example.   
The oligomeric nature of HSF1 in the interaction with Bag2 and Bag4 is still unanswered. The 
concentration used presently should not lead, at 4°C, to spontaneous concentration-dependent 
trimerization. However, the cell line from which these interactions were identified is most probably 
arrested in the attenuation phase, where HSF1 is supposed to be trimeric. The in vitro pull-downs 
performed here would have to be repeated, using this time trimeric HSF1.  
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4.3 Bag2 and Bag4 as in vitro nucleotide exchange factor 
 
The in vitro activities of Bag2 and Bag4_BD were measured in this work.  The stimulation of ADP release 
was measured for both Bag proteins, with Hsc70 and Hsp70, and Bag4_BD was shown to be much 
more efficient at stimulating ADP release than Bag2. Gässler and colleagues did a similar work with 
Bag1-M, one of the isoform of Bag1 in 2001. In her work, much higher concentration of nucleotide 
exchange factors could be tested, but it appeared that Bag1-M could stimulate ADP-release with an 
intermediate efficiency, when comparing with Bag2 and Bag4_BD (Gässler et al. 2001). Indeed, with 
Hsc70 as the chaperone, and for nucleotide exchange factor concentrations of 5 μM and 10 μM, Bag2 
had koff values of 1.75 s-1 and 3.4 s-1 respectively, Bag4_BD 37.5 s-1 and 50.5 s-1and Bag1-M had, with 
the same chaperone, and the same concentrations of NEF, koff values of approximately 15 s-1and 18 s-
1.  
For both active nucleotide exchange factors tested in this work, it appeared that the stimulation of 
ADP-release was more efficient on Hsc70 than on Hsp70. In Gässler et al, Hsp70 appeared to be slightly 
more sensitive than its cognate homolog to the actions of Bag1-M (Gässler et al. 2001). Differences 
between Hsp70 and Hsc70 are still not completely unraveled. Tutar and colleagues suggested that, in 
yeast, the main differences between the two chaperones reside in their ATPase domains, which have 
different roles (Tutar et al. 2006). They also bring evidence that Hsc70 fulfils roles in yeast growth that 
Hsp70 cannot take over. Altogether, the constitutive expression of Hsc70 hints its role in housekeeping 
mechanisms. However, Finka and Goloubinoff hinted that Hsp70 might also take charge of 
housekeeping roles, as it represents, in cancer cells and in the absence of stress, a copy number of 
about one third of all the proteins involved in the Hsp70 machineries (Finka & Goloubinoff 2013).  
Moreover, Hsc70, the most abundant 70 kDa molecular chaperone was also shown to be able to 
interact with Hsp110 to resolubilize heat-aggregated substrates. Hsp70 was shown to be less efficient 
in that role (Rampelt et al. 2012; Nillegoda et al. 2015; Gao et al. 2015). One would however expect 
that the heat-inducible Hsp70 would be more effective at refolding misfolded proteins during heat 
shock, but the different roles of these two chaperones are still elusive. The higher sensitivity of Bag2 
and Bag4 to Hsc70 could be linked to the abundance of the preferred Hsp70-like chaperone for which 
these nucleotide exchange factor are needed the most. Bag1 is known to regulate the degradation of 
some Hsp70 clients (Tsukahara & Maru 2010), and was linked to several proteasome subunits (Taipale 
et al. 2014). Its higher stimulation of Hsp70 might be then linked to the necessity of redirecting 
misfolded protein for degradation during cellular stress, when Hsp70 levels are increased. 
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Bag2 and Bag4_BD both showed similar effects on influencing the refolding by Hsc70 of heat-
denaturated luciferase despite the difference observed in their stimulation of ADP-release. In contrast 
to the data obtained by Gässler and colleagues for Bag1-M, no inhibition of Bag proteins at the 
concentrations measured was seen. It is however not possible to compare the data generated in this 
work to the ones obtained by Gässler and colleagues. Indeed, the stimulation of luciferase refolding 
by Bag1-M was measured in the presence of reticulocyte lysate, and a positive effect was only seen in 
the presence of inorganic phosphate at low concentrations of Bag1-M (Gässler et al. 2001). Also, the 
buffer used in these measurements were different than the ones used to measure the stimulation of 
luciferase refolding by Bag2 and Bag4_BD. Extensive work on Bag proteins was performed by Rauch 
and colleagues, but Bag4, or fragments of it, were never tested, and the heat-induced Hsp70 and not 
Hsc70 was used as the chaperone protein (Rauch & Gestwicki 2014; Rauch et al. 2016). As it was shown 
in this work that the stimulation of ADP-release can be highly chaperone dependent, their results are 
hardly comparable to the ones presented in this work.  
 
4.4 Bag2 and Bag4 tune up the heat shock response 
 
In Figure 18, evidence is presented that the overexpression of two nucleotide exchange factors of 
Hsp70 can activate the heat shock response by ending the attenuation of the trimer, or eventually, by 
allowing a trimer of HSF1 to bind back to the promoter of heat shock genes. This effect might be 
specific to Bag2 and Bag4, as the Bag domain of Bag4, although active in vitro for stimulating the 
release of ADP by the nucleotide binding domain of Hsp70 and in increasing the refolding rates of heat-
denaturated luciferase could not have this heat shock response activating effect in living cells. It was 
shown that both N-terminal domains of these two Bag proteins can interact with HSF1 in vivo and 
supposedly in vitro (Figure 9 and Figure 11 respectively). Despite these interactions, the N-terminal 
fragments of these nucleotide exchange factors were not able on their own, to lead to HSF1 trimer 
release from Hsp70/Hsc70. The full protein is therefore needed for such an effect.  
The earlier start of the attenuation phase observed (Figure 18) in the case of the overexpression of the 
two full-length nucleotide exchange factor could be explained by the fact that a stronger heat shock 
response, due to the overexpression of Bag2 and Bag4, would lead to a higher concentration of Hsp70 
in the cell. This would in turn lead to an earlier negative feed-back loop as less time would be needed 
to have enough chaperones to enter the attenuation phase. Similar effect was reported by Shi and 
colleagues, as an overexpression of Hsp70 was reported to hamper the capacity of HeLa cells to deploy 
a heat shock response (Shi et al. 1998a). In the present case, where Hsp70 is thought to be up-
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regulated, but not over-expressed, the cells are still able to mount a further heat shock response when 
submitted to temperature stress. This heat shock response is just attenuated earlier than in control 
cells. 
Recently, a similar effect of the S. pombe yeast orthologues Bag101 and Bag102 on the heat shock 
response was uncovered by Poulsen et al. They provide evidence that the overexpression of Bag101 
and Bag102 in yeast leads to constitutive HSF1 activation and growth defects in yeast presumably by 
prompting the release of HSF1 from Hsp70 (Poulsen et al. 2017). Bag101 and Bag102 are the only 
proteins of the Bag family in S. pombe, and even if their sequences homology related them more with 
human Bag1, it is possible that they overtake the role of Bag2 and Bag4 when it comes to hamper the 
repression of the transcription activity of trimeric HSF1. They however did not report any direct 
interaction between these Bag proteins and HSF1. 
Many co-chaperones of the Hsp70 machinery can bind to chaperone substrates. J-domains proteins 
are known to deliver substrate to Hsp70, and to stimulate Hsp70s ATP hydrolysis rate to ensure 
stronger affinity of the chaperone for its substrates. Hsp110s, also nucleotide exchange factors of 
Hsp70, were also shown to interact with misfolded proteins (Liu & Hendrickson 2007; Schuermann et 
al. 2010), even if this can be related to the intrinsic chaperone activity of Hsp110. It is however assumed 
that Hsp110s can interact with many misfolded proteins in a non-specific manner. In the case of co-
factors of the Bag family, substrate specificity is unclear. Taipale and colleagues identified families of 
substrates for every Bag protein (beside Bag2 who appeared to interact with most of Hsc70’s 
substrates), linking each of them to specific cellular pathways. Consistent to what was already 
suggested, the non-conserved sequences of the N-terminal domains of the Bag proteins allow to think 
that maybe substrate recognition is made through that part of the protein (Mayer & Bukau 2005). 
Another role of the N-terminal domain of Bag proteins was proposed recently: a bi-dentate mechanism 
in which non-Bag domain parts of Bag1 and Bag3 interact with the substrate binding domain of Hsc70 
to promote client release (Rauch et al. 2016). Rauch and colleagues also showed evidences that client-
release was still possible without Bag domain, but not nucleotide release. Such an interaction could 
compete with the client protein binding to Hsc70s’ substrate binding domain, and hence prevent 
rebinding. This could explain the effect described in Rauch et al. Gässler and colleagues did not 
compare the abilities of the full length Bag1, and of its Bag domain alone to promote substrate release 
(Gässler et al. 2001). A similar effect was shown in E. coli, where GrpE N-terminal domain interacts 
with the substrate binding domain of DnaK (Mally & Witt 2001; Chesnokova et al. 2003; Brehmer et al. 
2004).  Such a mechanism could exist for Bag2 and Bag4, even though the small size of the N-terminal 
fragment of Bag2 might render such an interaction not possible. If indeed Bag2 can just promote 
trimeric HSF1 release from Hsp70 through its Bag domain and not through interacting with the 
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substrate binding domain of Hsp70, it could explain the weaker up-regulation of the heat shock 
response by Bag2 (compared to Bag4)  when it is overexpressed in cells (Figure 18). This could also be 
explained by its much weaker ADP-release stimulation (Figure 15).  
Bag2 was shown to inhibit protein degradation, by interacting with the E3 ubiquitin ligase CHIP (Arndt 
et al. 1990). Longer association between Hsp70 and its substrate was shown to lead to its poly-
ubiquitination and therefore its degradation (Stankiewicz et al. 2010). By inhibiting CHIP, Bag2 would 
delay HSF1’s degradation by the proteasome system, hence leading to more stable HSF1 trimers. This 
effect could counter-act the weak ADP-release stimulation of Bag2. 
The fact that two nucleotide exchange factors were found to interact directly with HSF1, and that they 
both seem to act as positive regulators of the heat shock response is puzzling. More work would have 
to be conducted to unravel the implication of two nucleotide exchange factors up-regulating the heat 
shock response. Bag2 is the most abundant Bag protein in the cell (Finka & Goloubinoff 2013), but also 
much less active than Bag4 at stimulating the ADP-release. Moreover, it has been shown that Bag2 
does not show any client specificity, as the other Bag proteins do (Taipale et al. 2014). Therefore, there 
is a possibility that Bag4 is the canonical NEF acting as a positive regulator of the heat shock response, 
and that Bag2 is the non-specific NEF which can fulfil the same role, only less efficiently.  
Most recent studies suggest the existence of an equilibrium between monomer and dimer of HSF1. 
Concentration or temperature increase (and hence proteotoxic damages) would lead to trimerization, 
and acquisition of DNA-binding capacity (Hentze et al. 2016). The fact that HSF1 has some roles in the 
absence of cellular stress leads to two possibilities: either HSF1 is activated through another unknown 
mechanism, or trimeric HSF1 is present in the absence of stress. According to the model described by 
Hentze and colleagues in 2016, HSF1 trimerization can happen continuously at low levels, with the help 
of Hsp90. This ensures the existence of a basal pool of transcriptionally active HSF1, even in the 
absence of stress. The Hsp70/Hsp40 complex would then be responsible of moderating that basal 
transcription level of HSF1 target genes. Upon stress, the formation of trimer would be favored, and 
molecular chaperones normally maintaining HSF1 inactive would be titrated away, allowing for a 
longer time in which HSF1 could drive the synthesis of heat shock proteins in large quantities. 
Therefore, the overexpression of Bag2 or Bag4 increased the fraction of active HSF1 before stress by 
releasing trimeric HSF1 from Hsp70. Very recently, a mathematical model in which the titration of 
Hsp70 away from HSF1 leads to activation of the heat shock response in yeast was proposed (Zheng et 
al. 2016). This model, combined with the evidences presented in this work gives to Hsp70s a much 
more central role in the heat shock response. 
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Figure 19: Revised cycle of the heat shock response. HSF1 exists in an equilibrium between monomer 
and dimer (A). Certain conditions such as local concentration increase lead to trimerization, acquisition 
of DNA-binding activity, and protein synthesis (B). Hsp70 (or Hsc70) in complex with a J-domain protein 
(JDP) represses HSF1 transcription capacity (C). In the absence of stress, HSF1 goes back to the 
monomer dimer equilibrium (or is degraded) (E). Upon stress, Hsp70 is titrated away, and Bag2 and 
Bag4 assist substrate release (D), leading to a longer “DNA-bound time” of the trimer, hence a stronger 
heat shock response (B). With time, the very high concentration of chaperones, combined with the 
eventual end of the cellular stress might outnumber Bag2 and Bag4, which expression is not heat shock 
dependent, and monomerization of HSF1 might happen. 
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Chapter 5. Material and Method 
 
5.1 Materials 
 
5.1.1 Bacterial strains and plasmids 
 
5.1.1.1 E.coli K12 strains 
 
 Top 10  
 
 
 
BL21(DE3) RosettaTM 
 
 
MC 1061 
 
5.1.1.2 Plasmids 
 
Table 2: Plasmids used in this work 
pCA528 T7 promoter, KanR AG Mayer Lab 
collection 
pCA528_HsBag2 T7 promoter, KanR This work 
pCA528_HsBag2_BD T7 promoter, KanR This work 
pCA528_HsBag4 T7 promoter, KanR This work 
pCA528_HsBag4_BD T7 promoter, KanR This work 
pIRES-GFP II-HA CMV promoter, KanR Courtesy of AG 
Melchior 
pIRES-GFP II-CtermHA-HsHSF1 CMV promoter, KanR This work 
pIRES II-mCherry CMV promoter, KanR This work (S. Hennes) 
pIRES-3xmyc_rhGFP CMV promoter, KanR This work (S. Hennes) 
pcDNA4-TO Tet-ON promoter, AmpR Courtesy of AG 
Stoecklin 
F- mcrA ∆(mrr - hsdRMS- mcrBC) Φ80lacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara leu) 7697 
galU galK rpsL (StrR) endA1 nupG 
 
 
F- ompT gal dcm lon hsdSB (r-B m-B) λ(DE3[lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) pRARE(CamR) 
 
Δ(araA-leu)7697  [araD139]B/r  Δ(codB-lacI)3  galK16 
galE15(GalS)  λ-  e14-  mcrA0  relA1  rpsL150(strR)  
spoT1  mcrB1  hsdR2 
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pcDNA4-3xMYC-Bag4-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pcDNA4-3xMYC-Bag4_BD-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pcDNA4-3xMYC-Bag4_Nterm-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pcDNA4-3xMYC-Bag2-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pcDNA4-3xMYC-Bag2_BD-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pcDNA4-3xMYC-Bag2_Nterm-IRES-rhGFP CMV promoter, AmpR This work (S. Hennes) 
pIRES II CMV-rLuci-mCherry_pHSE-fluci CMV promoter, HSE 
promoter, KanR 
This work (S. Hennes) 
p273-GST-omega Arabinose promoter, 
AmpR 
AG Mayer Lab 
collection 
p273-GST-Bag2_BD Arabinose promoter, 
AmpR 
This work 
p273-GST-Bag2_NTD Arabinose promoter, 
AmpR 
This work 
p273-GST-Bag2 Arabinose promoter, 
AmpR 
This work 
p273-GST-Bag4_BD Arabinose promoter, 
AmpR 
This work 
p273-GST-Bag4_NTD Arabinose promoter, 
AmpR 
This work 
p273-GST-Bag4 Arabinose promoter, 
AmpR 
This work 
5.1.2 Mammalian cell lines 
 
U2-OS Courtesy of AG Stoecklin 
U2-OS pIRES-GFP II-CtermHA-HsHSF1 This work 
U2-OS pIRES-GFP II-HA This work 
       
5.1.3 Oligodesoxynucleotides 
 
All Oligodesoxynucleotides were ordered at Sigma-Aldrich 
 
Table 3: Oligodesoxynucleotides used in this work 
hsHSF_EcoRI_5 5’-CGGAATTCACCATGGATCTGCCCGTGGGCCC-3’ 
hsHSF1_HA_stop_NotI_3 5’-
AGTCGAGCGGCCGCTTAAGCGTAATCTGGAACATCGTATGGGTAGGAGA
CAGTGGGGTCCTTGGCTTTGGGAGG-3’ 
Bag2_BsmBI_5 5’-CCAGTGCGTCTCAGGTGGTATGGCTCAGGCGAAGATCAA-3’ 
Bag2_XhoI_3 5’-GATCCTCGAGCTAATTGAATCTGCTTTCAGCATTTTGTTG-3’ 
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Bag2_BD_BsmBI_5 5’GATCCCGCGGCGTCTCAGGTGGTATGCAAGAATCCCTGAAGCATGCCAC
-3’ 
Bag2_SacII_5 5’-GATCCCGCGGGGTCTCAGGTGGTATGGCTCAAGCGAAGATCAACGC-3’ 
Bag2_BD_SacII_5 5’-GATCCCGCGGGGTCTCAGGTGGTATGCAAGAATCCCTGAAGCA-3’ 
Bag2_NotI_3 5’-GATCGCGGCCGCTTAATTAAAACGGCTTTCAGCATTTT-3’ 
Bag2_Nterm_stop_NotI_3 5’-GATCGCGGCCGCTCATTCTTGCTGCTGGGGGTTACGA-3’ 
Bag4_BsmBI_5 5’-CCAGTGCGTCTCAGGTGGTATGTCGGCCCTGAGGCGCTC-3’ 
Bag4_BD_BsmBI_5 5’-CCAGTGCGTCTCAGGTGGTATGAGTACTCCTCCGAGTATTAA-3’ 
Bag4-HindIII_3 5’-CTCTAGAAGCTTCAGGCTTCCACTTTGTTCTAAATCC-3’ 
Bag4_SacII_5 5’-GATCCCGCGGGGTCTCAGGTGGTATGTCGGCCCTGAGGCGCTC-3’ 
Bag4_BD_SacII_5 5’-GATCCCGCGGGGTCTCAGGTGGTATGAGTACTCCTCCGAGTATTAA-3’ 
Bag4_NdeI_5 5’-GCAAAACATATGTCGGCCCTGAGGCGCTC-3’ 
Bag4_BD_NdeI_5 5’-GCAAAACATATGAGTACTCCTCCGAGTATTAA-3’ 
Bag4-SalI_3 5’-GCAAAAGTCGACTTCAGGCTTCCACTTTGTTCTAAATCC-3’ 
Bag4_Nterm_stop_SalI_3 5’-GCAAAAGTCGACTCATTCATCTGAAGGTACACATTCTTCA-3’ 
 
5.1.4 Chemicals, enzymes and kits 
 
Table 4: Chemical used in this work 
Acetic Acid (100%) Neolab 
Acetone J.T. Baker 
Acrylamide stock solution 30% (mixing ratio 37.5:1; 
Rotiphorese Gel 30) 
Roth 
Albumin Fraktion V Roth 
Aprotinin AppliChem 
8-[(4-Amino)butyl]-amino-ADP – MANT (MABA-ADP) Jena-Bioscience 
Adenosine-Tri-Phosphate (ATP) Roth 
Benzonase Sigma-Aldrich 
Bromophenol blue Waldeck 
Coomassie Brilliant Blue G-250 Roth 
1,2 Diaminocyclohexane-N,N,N’,N’ Sigma-Aldrich 
Digitonin Sigma-Aldrich 
Dimethyl-sulfoxyde (DMSO) VWR 
Dithiothreitol AppliChem 
Ethylenediaminetetraacetic acid AppliChem 
Ethylene glycol-bis(β-aminoethyl ether tetraacetic acid AppliChem 
Ethanol p.a., 99.9 % AppliChem 
Ethidium bromide (1% w/v in H2O) Roth 
Geneticin Gibco 
Glycerol Sigma-Aldrich 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Sigma-Aldrich 
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Hygromycin Roth 
Igepal (NP-40) Sigma-Aldrich 
Imidazole ACS 
Isopropyl-β-D-thiogalactopyranosid Roth 
Isopropanol VWR 
Kanamycin Roth 
Leupeptin Applichem 
Magnesium Chloride AppliChem 
2-Mercaptoethanol Roth 
Penicillin/Streptomycin Sigma-Aldrich 
Phenylmethylsulfonyl fluoride AppliChem 
Pepstatin AppliChem 
Polyethylenimine (PEI) Polysciences, Inc 
Potassium chloride Sigma-Aldrich 
Potassium Dihydrogen Phosphate AppliChem 
Protino© Ni-IDA Macherey-Nagel 
Protino© Glutathione agarose 4B Macherey-Nagel 
Rotiagarose NEEO Ultra Roth 
Saccharose Roth 
Sodium dodecyl sulfate Roth 
Sodium chloride Sigma-Aldrich 
Sodium Hydroxide Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane Sigma-Aldrich 
Trichloroacetic acid AppliChem 
Trifluoroacetic acid AppliChem 
Triton X-100 AppliChem 
Tween 20 Roth 
 
Table 5: Commercial standards and kits 
Page Ruler Prestained Protein Ladder Fermentas 
Mini-preps kit MiniBio GmbH 
Gel Extraction kit MiniBio GmbH 
Universal RNA purification kit EurX 
Gene RulerTM 1kb DNA Ladder Fermentas 
Chemiluminescent Substrate West Pico Thermo Scientific 
Random Hexamer Primers Thermo Scientific 
Light Cycler 480 SYBR Green I Master Roche 
Passive Lysis Buffer Promega 
Roti-Fect Plus transfection kit Roth 
 
Table 6: Proteins and enzymes 
Restriction enzymes New England biolabs 
T4 DNA Ligase Fermentas 
BSA New England biolabs 
M-MLV Reverse Transcriptase Promega 
RNAse inhibitor RNAsin Promega 
Firefly luciferase Lab collection 
Hsp70 Lab collection 
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Bag1 Lab collection 
Hdj1 Lab collection 
6xHis-Ulp1 Lab collection 
HSF1 Lab collection 
 
Table 7: Antibodies and antibodies-coupled beads 
Antibody Dilution Provider 
Anti HA.11 (1:1000 dilution) Covance 
Anti-myc (1:1000 dilution) Cell signaling 
Anti-Hsf1 (1:1000 dilution) Santa-Cruz biotechnologies 
Anti-Hsp70  (1:2000 dilution) Lab-stock 
Anti-Gst-ram2 (1:2000 dilution) Lab-stock 
Anti-Hsc70/Hsp70 (1:5000 dilution) Santa-Cruz biotechnologies 
Anti-mouse ECL  (1:10000 dilution) Dianova 
Anti-rabbit ECL  (1:10000 dilution) Dianova 
Anti-HA beads (A2095) - Sigma-Aldrich 
Anti-myc beads (A7470) - Sigma-Aldrich 
 
Table 8: Media and Serum 
Dubbeco‘s Modified Eagle Medium (DMEM) Life Technologies 
Fetal Calf Serum (FCS) Life technologies 
Luria-Bertani (LB) medium2 10 g/L tryptone 
5 g/L yeast extract 
5 g/L NaCl 
2X YT medium 16 g/L tryptone 
10 g/L yeast extract 
5 g/L NaCl 
 
Table 9: Equipment 
ÄKTA HPLC GE Healthcare 
Ressource Q column (6mL) GE Healthcare 
Superdex 75 GE Healthcare 
Superdex peptide GE Healthcare 
HiTrap Desalting column 5 mL GE Healthcare 
Fluorometer LS-35 Perkin-Elmer 
CD spectropolarimeter Jasco715 
Centrifuges Sorvall, Eppendorf, Heraeus 
Microfluidizer EmulsiFlex-C5 Avestin 
Stopped-Flow instrumentation SX-18MV Applied Photophysics 
SDS-PAGE gel chambers for minigels Biorad 
Trans Blot© Turbo™ Biorad 
UV/VIS sprectrophotometer NanoDrop PeqLab 
                                                          
2 For Petri dishes, 15 g/L agar is added 
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Thermomixer Eppendorf 
Liquid chromatograph Ultimate 3000 Dionex 
Mass spectrometer ORBITRAP ELITE Thermo Scientific 
Mass spectrometer Maxis Bruker 
Biolumat Berthold 
Luminescent Image Analyzer LAS 4000 FujiFilm 
HeraCell 150i CO2 incubator Thermo Scientific 
LunaTM fl cell counter Logos 
 
Table 10: Software 
ApE M.Wayne Davis 
Prism 5.0 GraphPad software 
Microsoft Office 2013 Microsoft 
Mendeley Desktop Mendeley Ltd. 
ImageJ Wayne Rasband 
 
5.2 Common solutions and buffers 
 
 
Agarose gel electrophoresis 
Sample loading buffer (5X) 
Bromophenol blue 0.1 % (w/v) 
Xylencyanol blue 0.2 % (w/v) 
Orange G 0.2 % (w/v) 
Glycerol 50 % (v/v) 
EDTA 50 mM 
SDS 1 % (w/v) 
TAE buffer 
TRIS 40 mM 
Acetic acid 20 mM 
EDTA 1 mM 
 
 
Coomassie Staining 
Staining solution 
Methanol 30 % (w/v) 
Acetic acid 10 % (v/v) 
Coomassie Brilliant Blue R-250 0.25 % (w/v) 
 
De-staining solution 
Methanol 30 % (v/v) 
Acetic acid 10 % (v/v) 
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SDS-PAGE 
5X Laemmli Buffer 
TRIS (pH 6.8) 0,5M 
4,4% SDS 
20% glycerol 
2-Mercaptoethanol 2% 
Bromophenol-blue 0,6% 
 
1X running-buffer pH 8.3 
TRIS 25mM 
Glycine 200mM 
SDS 0.1% 
 
 
Cell-culture 
Phosphate buffered saline (PBS) 
NaCl 137 mM 
KCl 27 mM 
Na2HPO4 8.1 mM 
KH2PO4 1.5 mM 
 
PBS- EDTA 
NaCl 137 mM 
KCl 27 mM 
Na2HPO4 8.1 mM 
KH2PO4 1.5 mM 
EDTA 0.8 mM 
 
5.3 Methods 
 
5.3.1 Cell culture and transfection 
 
5.1.1.1 Cultivation of cells 
 
In this work, U2-OS cells were cultivated in DMEM, supplemented with 10% FCS and 1% Penicillin/ 
Streptomycin, in an atmosphere containing 5% CO2 and, unless said otherwise, at a temperature of 
37°C. When cultures became subconfluent, cells were passaged by resuspending them in PBS-EDTA, 
and diluting them in fresh growth-media. 
If needed, cells were counted using the LunaTM fl cell counter. The cell suspension whose concentration 
was to be measured was diluted 1:1 with 0.1% Trypan Blue before measurement. 
5.1.1.2 Transfection 
 
Per default, transfection was performed using Polyethylenimine (PEI) as a transfection reagent. Cells 
were seeded so that they would reach 60% confluency on the next day. For a 10 cm cell culture dish 
to be transfected, 1.5 mL DMEM (without FCS, not antibiotics) were mixed with 30 μL of a PEI (stock 
solution at a concentration of 1 mg/mL), and with 12 μg of plasmid DNA. The mixture was gently 
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vortexed, and incubated for 10 min at room temperature. 4.5 mL of DMEM (supplemented with FCS 
and antibiotics) was added, and the mixture was added dropwise to the cells. The medium was 
changed 7 hours later. For transfection of 15 cm culture dishes, the quantities were increased 
accordingly. In case of a transient transfection, the cells were harvested after 48 hours as well. 
In case of stable transfections, antibiotic selection was applied 48 hours after transfection, and 
successfully transfected cells were later enriched through Fluorescence Assisted Cell Sorting (FACS), 
using the presence of GFP or mCherry in the cytoplasm as a criteria of successfully transfected cells. 
Three to four sorts were performed for each cell line over 2 months. 
In the case of dual transient transfections the Rotifect-Plus reagent was used, in order to increase 
transfection efficiency and according to manufacturer’s instructions. 20 μg DNA from each plasmid to 
be transfected were used for a 15 cm diameter dish. The DNA/lipid complex was only incubated with 
the cells for 2 hours, so cell mortality could be reduced. Transfection efficiency was assayed with FACS 
24 hours after transfection, and cells were harvested after 48 hours. 
 
5.1.1.3 Cryo-conservation of cultivated cells 
 
Subconfluent cells were resuspended in PBS-EDTA, centrifuged at 1000 rpm for 10 min at 4°C and 
resuspended in 1 mL medium containing 50% FCS and 10% DMSO. The cells were then frozen at -80°C 
for 24 h and kept in liquid nitrogen for long-term storage. 
Cells cryo-tubes were thawed in 70% Ethanol, previously warmed-up at 37°C, and added to a 15 cm 
culture dish containing 25 mL DMEM (supplemented with 10%FCS and 1% Penicillin/Streptomycin), so 
that the DMSO is too diluted to harm growing cells. 
 
5.3.2 Molecular biology techniques 
 
5.3.2.1 Cloning techniques 
 
Total RNA isolation 
Total RNA was isolated with the Universal RNA purification kit according to the manufacturer’s 
instructions. RNA concentration was determined by measuring its absorbance (230 – 400 nm) using a 
NanoDrop spectrometer. 
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Generation of cDNA 
1 μg of total RNA was mixed with distilled water so that the total volume would be 14 μL. 1 μL Random 
Hexamer primer was added. This was incubated 5 minutes at 70°C, before being kept on ice for at least 
5 minutes. 5 μL M-MLV RT 5X buffer, 2.5 mM DNTPs, 0.5 μL RNAsin, 0.5 μL M-MLV RT RNAse and 1.5 
μL distilled water were them added. The whole mixture was then incubated for 1 h at 37°C. 
Concentration was then assayed with the NanoDrop. 
 
Polymerase chain reaction 
Unless the gene of interest was already cloned, 1 μg of total cDNA was used as a template for PCR. If 
already cloned, 100 ng of template DNA would be used. 
Standard PCR protocol: 
   Template DNA    100 ng 
   dNTPs (10 mM)    1 μL 
   Each primer (10 pmol/μL)  0.5 μL 
   10 X buffer    5 μL 
   OptiTaq polymerase (2.5 U/μL)  1 μL 
   Distilled H2O    up to V final = 50 μL 
Standard PCR program: 
Step 1   Melting 9°C 2 min 
Repeat step 2-4 30X 
Step 2   melting 96°C 1min 
Step 3   annealing 50-60°C (primers-dependent) 30s 
Step 4   elongation 68°C 5min 
Step 5    pause 4°C 
 
Amplified DNA was then purified either through Agarose Gel, followed by MiniBio GmbH Gel extraction 
kit, or using the PCR purification kit from MiniBio GmbH. 
 
Restriction digestion of DNA 
 
Restriction enzymes (type II endonuclease) from New England Biolabs were used to digest the 3’ and 
5’ ends of the PCR products, as well as to open the wished vector, hence forming compatible ends 
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between each other’s. Buffer used, temperature and incubation time were chosen according to the 
manufacturer’s instructions. 
Digested PCR fragments and digested vectors were then loaded on an agarose gel, bands were cut, 
and DNA was purified using the Gel Extraction kit from MiniBio GmbH. 
 
Ligation of DNA fragments 
 
The T4 DNA ligase was later used to form phosphodiester bonds between compatible ends of PCR 
fragments and linearized vector. Reactions were conducted for 30 minutes at 30°C. Molar ratios of 
vector to insert were 1:3. 
 
Preparation of competent E. coli cells and transformation 
 
Transformation were made in chemically competent E. coli cells. These cells were first grown to OD600 
of 0.4-0.5 in about 30mL of LB medium. After centrifugation, cells were washed twice and then 
resuspended in ice-cold 60mM CaCl2 + 15% glycerol. This solution was previously sterilized. This cell 
suspension was incubated on ice for 1 hour. The cells were then aliquoted (100 μL) and snap-frozen in 
liquid nitrogen. Storage was done at -80°C. 
Competent E. coli were thawed on ice, and 2-5 μL of ligation mixture were added. An incubation of 5 
minutes on ice followed. The mixture was subsequently heat-shocked for 1 minute at 42°C, before 
being put back on ice for 5 minutes. 1 mL of LB medium was then added, and the cells were allowed 
to recover for 1 hour at 37°C. Centrifugation for 1 minute at 6000 rpm followed. After removing most 
of the supernatant by decanting, the pellets were resuspended in the remaining medium, and spread 
onto LB-agar Petri dishes, containing the appropriate antibiotic. The dishes were then incubated 
overnight at 37°C.   
 
 
5.3.2.2 Quantitative real-time polymerase chain reaction 
 
cDNA were synthetized  as described previsouly. Samples were analyzed in triplicate on a 384-wells 
plate using the Light Cycler© 480 II from Roche. The cDNA obtained were first diluted five times, and 
the PCR primers were diluted to 10 pmol/ μL. For each replicate, 2.5 μL of cDNA dilution, 5 μL of 2X 
SYBR Green Master Mix, 0.4 μL of each primer dilution and 1.7 μL of distilled water were mixed. HPRT1 
was used for internal normalization. The PCR program used was the following: 
   
71 
 
   Step 1:    95°C 5 min 
   Repeat step 2-4 40X 
   Step 2    95°C 10 s 
   Step 3    55°C 20 s 
   Step 4    72°C 10 s 
 
The qPCR primers used are the following: 
qPCR_HSPA1A_5 5’-ACCTTCGACGTGTCCATCCTGAC-3’ 
qPCR_HSPA1A_3 5’-TGGTTCACCAGCCTGGTTGTCAAA-3’ 
qPCR_HSPA8_5_c 5’-CAGAAGATTCTGGACAAGTG-3’ 
qPCR_HSPA8_3_c 5’-GTTGCAAACTTTCTCCCAGCT-3’ 
HPRT1_housekeeping_5 5’- TGACACTGGCAAAACAATGCA-3‘ 
HPRT1_housekeeping_3  5’- GGTCCTTTTCACCAGCAAGCT-3 
 
5.3.3 Immunoprecipitation and Western Blot 
 
Modified Wade Harper Buffer (MWHB) 
TRIS-HCl (pH 7.5) 50 mM 
NaCl 150 mM 
0.5% NP-40 
EDTA 5mM 
EGTA 5mM 
DTT 1 mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
 
IP elution buffer 
1X TB buffer 
NaCl 100 mM 
HA peptide 0.2 mg/mL 
0.2% Digitonin 
 
 
Glutathione elution buffer 
TRIS-HCl (pH 7.5) 50 mM 
Glutathione 10mM 
DTT 5 mM 
Glycerol 10 % 
 
TB buffer (10X) 
HEPES (pH 7.3) 200mM 
K(CH3COO) 1.1 M 
Mg(CH3COO)2 20 mM 
EGTA 10 mM 
 
Lysis buffer (TNS) 
TRIS-HCl (pH 7.5) 50 mM 
NaCl 300 mM 
Saccharose 10% 
2-Mercaptoethanol 3mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
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5.3.3.1 Immunoprecipitation 
 
Adherent cells were scraped from the dish in Modified Wade Harper Buffer (MWHB). 1 μL Benzonase 
were added, and the lysates were incubated for 15 minutes et 4°C. This step is meant to degrade 
genomic DNA in the cells. The lysates were thereafter clarified by centrifugation at 18.000 rpm for 30 
minutes, at 4°C. The clarified lysates were then incubated with anti-HA, or anti-myc beads, for 2.5 
hours (in the case of immunoprecipitation followed by mass-spectrometry analysis), or 30 minutes (in 
case of immunoprecipitation followed by a Western-Blot). The beads were later washed several times 
with 1 mL MWHB, for 10 minutes each, at 4°C. 
Interacting proteins were eluted differently differently whether mass-spectrometry or 
immunoblotting was performed afterwards. In both cases any residual liquid would be removed 
carefully from the beads with the micropipette. If the immunoprecipitation was followed by Western-
blotting, the beads were resuspended in 2X Laemmli buffer, and cooked for 5 minutes at 96°C. If the 
immunoprecipitation was followed by mass-spectrometry analysis, the beads were resuspended in 200 
μL IP elution buffer, and incubated 10 minutes at 30°C, with shaking, to prevent sedimentation of the 
beads. This step was repeated two more times. 
The 600 μL eluate were then concentrated by TCA precipitation: Trichloacetic Acid (TCA) was added to 
the eluate so that its final concentration was 12%, and incubated on ice for 1 h. Centrifugation at 
20,000 g/ 4°C for 30 minutes followed: The supernatant was carefully removed using the micropipet. 
The pellet was washed with acetone, and a second centrifugation, as previously described, followed. 
The acetone was then removed with the micropipette, and the pellets were air-dried for 30 minutes. 
The pellets were finally resuspended in 50 μL 2X Laemmli Buffer, and cooked 5 minutes at 96°C. 
In the case of in vitro pull-downs, GST fusion of the Bag constructs were expressed in MC 1061 strain, 
overnight at 20°C. Cells pellets were resuspended in Lysis buffer (TNS), and lysed through sonication 
(output 5 / 3 times 10 pulses). Cell extracts were then clarified by centrifugation at 13000 rpm for 15 
minutes, at 4°C. Clarified lysates were subsequently incubated with 20 μL Protino-Glutathione agarose 
for 30 minutes at 4°C, and with or without 2 μM of purified HSF1. Agarose beads were then washed 
once with lysis buffer, and later the GST-fusion protein were eluted in 40 μL Glutathione elution buffer 
for 30 minutes at 4°C.  
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5.3.3.2 SDS-PAGE and immunoblotting 
 
In this work, 12% and 16% acrylamide separation gels were prepared and used. 
 
Table 11: Gel preparation scheme for SDS-PAGE 
Substance Separation gel 12% Separation gel 16% Stacking gel 6% 
Acrylamide 12% [v/v] 16% [v/v] 6% [v/v] 
Tris-Hcl, pH 6,8 - - 125 mM 
Tris-Hcl, pH 8,8 375 mM 375 mM - 
SDS 10% 0.1% [w/v] 0.1% [w/v] 0.1% [w/v] 
Ammonium persulfate (APS) 10% 0.6% [w/v] 0.6% [w/v] 0.05% [w/v] 
TEMED 0.06% [v/v] 0.06% [w/v] 0.01% [v/v] 
 
Whole protein cell lysates, or purified proteins were mixed with 5X Laemmli buffer, so that the final 
concentration of Laemmli buffer would be 1X. After 5 minutes heating at 96°C, samples, and molecular 
ladder would be loaded into the wells of the gels, and separated with 120 V for 20 minutes, followed 
by 45 minutes to 2 hours with 180 V in running buffer. When no Western Blot was needed, the gels 
were stained with coomassie staining for 1 hour, and de-stained with de-staining solution. 
For immunoblotting, the separated proteins were transferred on a PVDF membrane using the Trans 
Blot© Turbo™, and according to the manufacturer’s default procedure. After blocking of unspecific 
binding using 3% Milk/PBS-Tween (0.1%) for 30 minutes, cells were incubated with the appropriate 
antibody at the appropriate dilution, in blocking solution, overnight, at 4°C. Next day, the membranes 
were washed 7-8 times with PBS-Tween (0.1%) for 5 minutes, before being incubated for 2 hours at 
room temperature with the appropriate secondary antibody coupled with the Horseradish Peroxidase, 
diluted in blocking solution. Membranes were once again washed 7-8 times with PBS-Tween (0.1%) for 
5 minutes. All incubations were performed on a roller shaker in a 50 mL tube. Protein bands were 
detected using the Chemiluminescent Substrate West Pico reagent, and the LAS 4000 instrumentation. 
 
5.3.4 Analysis by Shotgun Proteomics 
 
Eluates from immunoprecipitations were processed and analyzed by the Core Facility for mass 
spectrometry and proteomics of the ZMBH (Zentrum für Molekularebiologie Heidelberg). The 
Proteome of U2-OS pIRES-GFP II-CtermHA-HsHSF1 cells was hence compared to the proteome of U2-
74 
 
OS pIRES-GFP II-HA cells using the Dimethyl labelling method. Control cell eluates were labelled after 
trypsin digest with light dimethyl (H2CO/NaBH3CN) and HA-HSF1 cell eluates with medium 
(D2CO/NaBH3CN) dimethyl (+4 Da). 
The eluates were run separately on SDS-PAGE, and fractions on the gels were cut. Samples were 
reduced with DTT, alkylated with iodoacetamide, before being digested with trypsin, whereas  digested 
peptides were then extracted from the gel pieces with 50% acetonitrile/0.1% trifluoroacetic acid (TFA), 
concentrated with a SpeedVac vacuum centrifuge, and diluted in 0.1% TFA, so that the total volume 
reaches 30 μL. 10 μL of it were analyzed with a nano HPLC (Dionex Ultimate 3000), coupled to an 
Orbitrap Elite mass spectrometer (Thermo Scientific). Sample was loaded onto a C18 Acclaim 
PepMap100 trap-column (Thermo Fisher Scientific) with a flow rate of 30ul/min 0.1% TFA. Peptides 
were eluted and separated on an C18 Acclaim PepMap RSLC analytical column (75um x 250mm) with 
a flow rate of 300nl/min in a 90 min gradient of 3% buffer A (0.1% formic acid) to 40% buffer B (0.1% 
formic acid, acetonitrile. A full peptide scan was followed by up to 15 MS/MS scans. The peptides found 
were compared to the UniProt database, taking into account the carbamidomethylation of the 
cysteines, and the eventual oxidation of Methionine and acetylation of protein N-termini. Data were 
analyzed with MaxQuant 1.5.2.8 and later with MaxQuant 1.5.3.30 and standard settings. 
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Figure 20: Dimethyl labeling workflow. 
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5.3.5 Protein expression and purification 
 
Lysis buffer (TNS) 
TRIS (pH 7.5) 50mM 
NaCl 300mM 
Saccharose 10% 
2-Mercaptoethanol 3mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
 
High salt buffer 
TRIS (pH 7.5) 50mM 
NaCl 1M 
Saccharose 10% 
2-Mercaptoethanol 3mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
 
Elution buffer 
TRIS (pH 7.5) 50mM 
NaCl 300mM 
Saccharose 10% 
2-Mercaptoethanol 3mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
Imidazole 300mM 
 
HKM-buffer 
HEPES (pH 7.6) 25mM 
KCl 150mM 
MgCl2 5mM 
  
ATP-buffer 
HEPES (pH 7.6) 25mM 
KCl 150mM 
MgCl2 5mM 
5 mM ATP 
 
Buffer A 
HEPES (pH 7.6) 25mM 
KCl 10mM 
MgCl2 5mM 
 
Buffer B 
HEPES (pH 7.6) 25mM 
KCl 1M 
MgCl2 5mM 
 
Buffer C 
Sodium-Phosphate buffer (pH 7.2) 50mM 
NaCl 300mM 
Glycerol 10 % 
2-Mercaptoethanol 3mM 
PMSF 1mM 
8 μg/mL Pepstadin 
10 μg/mL Aprotinin 
5 μg/mL Leupeptin 
 
 
 
All protein purified were expressed as 6xHis-SUMO fusion in BL21(DE3) RosettaTM. The cultures were 
grown at 37°C in 2xYT medium containing kanamycin. Once the optical density at 600 nm reached 0.7 
– 0.9, the cultures were induced with either 1 mM IPTG or 0.2% L(+)-arabinose. Expression proceed 
differently according to the protein purified: Bag2 full length was expressed for 5 h at 25°C. The Bag 
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domain of Bag2 (Bag2_BD) overnight at 20°C, and the Bag Domain of Bag4, for 4 h at 30°C. Hsc70 was 
expressed overnight at 25°C. 
At the end of expression, the cells were harvested by centrifugation at 5000 rpm for 15 minutes, and 
pellets were frozen dry, if the expression was not overnight. On the day of the purification, the pellets 
were resuspended in Lysis buffer (30 mL buffer / 1 L of culture) and lysed with a Micro fluidizer. The 
lysates were then clarified by centrifugation at 18000 rpm for 30 minutes. The supernatant was 
incubated with 0.5 g – 1 g of Protino resin (Ni-IDA, Macherey-Nagel) for 15-20 minutes at 4°C. The 
mixture was thereafter poured onto a polypropylene column where the resin with loaded material 
would sediment, and the flow-through hence be separated. The column with loaded material would 
then be washed with 20 column volumes of lysis buffer, followed by 20 column volumes of High-salt 
buffer. In the case of Hsc70 purification, all purification buffers were HKM based, and a wash with 10 
column volumes of ATP-buffer was performed before the high-salt wash, in order to remove bound 
substrates from Hsc70. Proteins were eluted with 5 mL of elution buffer, and fractions of 0,5 mL were 
collected. Fractions containing the protein were pooled. From this point, each purification differs. 
5.3.5.1 Purification of Bag4 Bag Domain 
 
The pooled fraction after elution were pooled together, and dialyzed overnight at 4°C against HKM 
buffer, with subsequent Ulp1 digestion of the SUMO tag. On the next day, the dialyzed protein were 
incubated with 0.5 g of Protino resin, in order to remove Ulp1, free SUMO, and any protein that would 
bound to the protein in an unspecific manner. The flow-through would contain the protein. Purity was 
checked by SDS-PAGE. 
5.3.5.2 Purification of Bag2 full length 
 
After Nickel affinity purification, the fractions collected were pooled, and the buffer was changed into 
HKM buffer on a HiTrap desalting column. This step was meant to remove Imidazole from the protein 
solution. For the next step, fresh Protino beads were saturated with Ulp1: 0.1g Protino were incubated 
with 2g Ulp1 in 10 mL HKM buffer for 15min at 4°C. The mixture was then centrifuged for 2 minutes at 
1000 rpm, and the supernatant was removed. The beads were washed twice in 10 mL HKM buffer. 
The Imidazole-free Bag2 solution was then mixed with the beads, and incubated for 2 hours at 4°C. 
This step was necessary to ensure that Bag2 would not interact with the Protino resin in a His tag 
independent fashion, which appeared to be the case.  
Next, a gel filtration with a Superdex 75 column was performed, and purity was checked by SDS-PAGE. 
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5.3.5.3 Purification of Bag2_BD 
 
In the case of the Bag Domain of Bag2, the Lysis buffer used was Buffer C, and high salt (with 1M NaCl) 
and elution (with 300 mM Imidazole) version of it were used. After Nickel affinity purification, the 
protein was dialyzed overnight against HKM buffer, with subsequent Ulp1 digest. Next day, a gel 
filtration on Superdex Peptide 10/300 GL was performed. 
 
5.3.5.4 Purification of Hsc70 
 
After Nickel affinity purification, buffer exchange was performed on a HiTrap desalting column, and 
overnight incubation with Ulp1 followed. On the next day, a second incubation with Protino was made, 
to remove uncut protein, alongside with Ulp1 and free SUMO. A new buffer exchange were performed, 
in order to put the protein in Buffer A. Ion-exchange chromatography on a Resource Q column 
followed. The column was pre-equilibrated in buffer A. Hsc70 was eluted from the column by a linear 
gradient from 0 to 100 % of Buffer B within 15 column volumes. Purity was checked by SDS-PAGE. 
5.3.5.5 Determination of the protein concentration 
 
The protein concentrations were determined with the Bradford assay (Biorad). In this assay, absorption 
at 595 nm of a dilution of the protein into Bradford reagent is measured on a spectrophotometer. A 
calibration curve was prepared using BSA as a standard. 
 
5.3.6 Biochemical assays 
 
5.3.6.1 Luciferase refolding assay 
 
Refolding buffer 
HEPES (pH 7.5) 25mM 
Potassium-Acetate 50mM 
Magnesium-Acetate 10mM 
ATP 2mM 
DTT 5mM 
 
Firefly Assay buffer A 
Glycylglycine (ph 7.4) 25mM 
K2PO4 100mM 
KH2PO4 100mM 
ATP 5mM 
Potassium-Acetate 100mM 
Magnesium-Acetate 15mM 
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Firefly luciferase (25 nM) was mixed with Hsc70 (2 μM) and Hdj1 (1 μM) in refolding buffer, and 
denaturated by heat treatment at 42°C for 10 minutes. After Heat-Shock, Bag2 or Bag4 was added to 
the desired concentration, and incubated at 30°C. At a given time-point, 2 μL of the reaction mixture 
were taken, and mixed with 123 μL of Firefly assay buffer A, and subsequently mixed with 125 μL of 
luciferin (160 μM) in a Biolumat. The measurement started directly after adding of luciferin, and lasted 
for 5 seconds. 
 
5.3.6.2 Luciferase assay on cell lysates 
 
Renilla Assay buffer 
NaCl 1,1 mM 
Na2EDTA 2,2 mM 
K-Phosphate buffer (pH 5.1) 0.22 mM 
BSA 0.44 mg/mL 
NaN3 1.3 mM 
Coelenterazine 1.43 μM 
Firefly Assay buffer 
Glycylglycine (pH 7.4) 25 mM 
K-Phosphate buffer (pH 8.0) 15 mM 
Potassium-Acetate 100mM 
Magnesium-Acetate 15 mM 
ATP 2 mM 
DTT 1 mM 
Luciferin 75 μM 
 
Luciferase Lysis buffer (5X) 
Tris-HCl (pH 7.8) 125 mM 
1,2 Diaminocyclohexane-N,N,N’,N’ 10 mM 
Glycerol 50 % 
Triton X-100 5 % 
DTT 2mM 
 
 
Cells were scraped from the dish in Luciferase Lysis buffer (1X), vortexed, and centrifuged 2 minutes 
at 4°C at 12,000 g. Cell extracts were then flash-frozen in liquid nitrogen, and stored at -80°C. Before 
measurement, cells were thawed on ice, and 10 μL of the lysate was mixed with 115 μL of Firefly assay 
buffer A, and subsequently mixed with 125 μL of luciferin (160 μM) in a Biolumat. Measurement 
started directly after adding of luciferin, and lasted for 20 seconds. 
In case of dual luciferase assay, the cell were lysed with Passive Lysis Buffer (Promega), according to 
manufacturer’s instructions, to ensure fast and complete lysis. 20 μL of lysate were used, and first 
mixed with 125 μL of Firefly assay buffer. Measurement started directly, and lasted for 10 seconds. 
125 μL of Renilla assay buffer was then added. This buffer would deactivate firefly luciferase (Dyer et 
al. 2000), and allow that only the activity of Renilla luciferase is measured. Measurement started 
directly after injection, and lasted for 10 seconds as well.  
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5.3.6.3 Kinetics of ADP-release 
 
0.5 μM of Hsc70 or Hsp70 were mixed with 0.5 μM MABA-ADP, and incubated 30 minutes at 30°C, and 
subsequently rapidly mixed with a solution containing 1 mM ATP and  Bag2, Bag2_BD or Bag4_BD, at 
the desired concentration. Mixing was performed at 30°C in a stopped-flow device SX.18MV.  The 
samples were excited at 360 nm and the decrease in fluorescence was measured using a 420 nm cut-
off filter. A single-exponential function was fitted to the obtained traces, and the rate constants of 
ADP-release were hence obtained. 
 
5.3.7 Circular Dichroism 
 
Circular Dichroism (CD) consist in the interaction of polarized light with optically active chiral 
molecules. Ultra violet CD is used to investigate the secondary structure of proteins. In this case, the 
chirality of the peptide bond strongly contribute to the CD spectrum of the protein. In a CD spectrum, 
two minima at 222 and 208 nm and a maximum peak at 195 nm are characteristic of a α-helical 
structure. On the contrary, a maximum at 195 nm, and a broad single minimum around 215 are seen 
in the CD spectra of a polypeptide rich in β-sheets. 
In this work, the proteins to be analyzed were dialyzed overnight in 10 mM Sodium-Phosphate buffer 
at pH 7.6. At least 140 μL of protein dilution were placed in a 1.0 cm x 0.1 cm quartz cuvette, and the 
CD spectrum was obtain with a Jasco 715 CD spectropolarimeter. A temperature gradient of 10-90°C 
was applied to the sample, in order to obtain a denaturation curve. 
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